###begin article-title 0
###xml 99 102 99 102 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 109 112 105 108 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 113 118 <span type="species:ncbi:10090">mouse</span>
An improved model to study tumor cell autonomous metastasis programs using MTLn3 cells and the Rag2-/- gammac-/- mouse
###end article-title 0
###begin p 1
###xml 933 936 933 936 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 942 945 938 941 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1336 1339 1332 1335 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1346 1349 1338 1341 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 90 98 <span type="species:ncbi:9606">patients</span>
###xml 426 429 <span type="species:ncbi:10116">rat</span>
###xml 518 523 <span type="species:ncbi:10090">mouse</span>
###xml 785 789 <span type="species:ncbi:10116">rats</span>
###xml 832 837 <span type="species:ncbi:9606">human</span>
###xml 946 950 <span type="species:ncbi:10090">mice</span>
###xml 1077 1081 <span type="species:ncbi:10090">mice</span>
###xml 1241 1246 <span type="species:ncbi:10090">mouse</span>
###xml 1350 1355 <span type="species:ncbi:10090">mouse</span>
The occurrence of metastases is a critical determinant of the prognosis for breast cancer patients. Effective treatment of breast cancer metastases is hampered by a poor understanding of the mechanisms involved in the formation of these secondary tumor deposits. To study the processes of metastasis, valid in vivo tumor metastasis models are required. Here, we show that increased expression of the EGF receptor in the MTLn3 rat mammary tumor cell-line is essential for efficient lung metastasis formation in the Rag mouse model. EGFR expression resulted in delayed orthotopic tumor growth but at the same time strongly enhanced intravasation and lung metastasis. Previously, we demonstrated the critical role of NK cells in a lung metastasis model using MTLn3 cells in syngenic F344 rats. However, this model is incompatible with human EGFR. Using the highly metastatic EGFR-overexpressing MTLn3 cell-line, we report that only Rag2-/-gammac-/- mice, which lack NK cells, allow efficient lung metastasis from primary tumors in the mammary gland. In contrast, in nude and SCID mice, the remaining innate immune cells reduce MTLn3 lung metastasis formation. Furthermore, we confirm this finding with the orthotopic transplantation of the 4T1 mouse mammary tumor cell-line. Thus, we have established an improved in vivo model using a Rag2-/- gammac-/- mouse strain together with MTLn3 cells that have increased levels of the EGF receptor, which enables us to study EGFR-dependent tumor cell autonomous mechanisms underlying lung metastasis formation. This improved model can be used for drug target validation and development of new therapeutic strategies against breast cancer metastasis formation.
###end p 1
###begin title 2
Electronic supplementary material
###end title 2
###begin p 3
The online version of this article (doi:10.1007/s10585-009-9267-6) contains supplementary material, which is available to authorized users.
###end p 3
###begin title 4
Keywords
###end title 4
###begin title 5
Introduction
###end title 5
###begin p 6
###xml 257 258 257 258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR1">1</xref>
###xml 352 353 352 353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR2">2</xref>
###xml 354 355 354 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR4">4</xref>
###xml 547 548 547 548 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR5">5</xref>
###xml 55 60 <span type="species:ncbi:9606">women</span>
Breast cancer is the most common cause of cancer among women and the second leading cause of cancer deaths in Western countries. The metastatic spread of tumor cells from their primary site to distant organs in the body is the principal cause of mortality [1]. Thus, understanding metastasis is one of the most significant problems in cancer research [2-4]. A key challenge is to develop suitable animal models to enhance our understanding of the mechanisms that underlie metastatic progression and to evaluate treatments for metastatic diseases [5].
###end p 6
###begin p 7
###xml 185 186 185 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR5">5</xref>
###xml 187 188 187 188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR8">8</xref>
###xml 510 511 510 511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR5">5</xref>
###xml 807 808 807 808 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR9">9</xref>
###xml 135 139 <span type="species:ncbi:10090">mice</span>
###xml 373 378 <span type="species:ncbi:9606">human</span>
###xml 504 508 <span type="species:ncbi:10090">mice</span>
###xml 709 714 <span type="species:ncbi:10090">mouse</span>
Currently available in vivo models of breast tumor progression and metastasis include transplantable models and genetically engineered mice that develop primary and metastatic cancers [5-8]. Transplantable tumor models include syngeneic models, in which the cancer cell line/transplanted tissue is of the same genetic background as the animal, and xenograft models whereby human cancer cell lines or tissues are transplanted into immunocompromised hosts, such as nude and severe combined immunodeficient mice [5]. Breast xenograft tumors are produced by injecting breast cancer cells into the flank (subcutaneous) or preferably into the mammary fat pad (orthotopic) of a female animal. Subcutaneous xenograft mouse models are typically the standard for cancer drug screening in the pharmaceutical industry [9], but the use of orthotopic xenotransplantation models should be favored since tissue specific stromal cell interactions play a crucial role in the biology of cancer progression and metastasis.
###end p 7
###begin p 8
###xml 138 139 138 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR2">2</xref>
###xml 141 142 141 142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR3">3</xref>
###xml 433 435 433 435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR10">10</xref>
###xml 437 439 437 439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR11">11</xref>
###xml 606 608 606 608 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR12">12</xref>
###xml 610 612 610 612 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR13">13</xref>
###xml 670 672 670 672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR14">14</xref>
###xml 673 675 673 675 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR16">16</xref>
###xml 194 199 <span type="species:ncbi:10090">mouse</span>
###xml 303 306 <span type="species:ncbi:10116">rat</span>
###xml 833 838 <span type="species:ncbi:10090">mouse</span>
Metastasis is a consequence of multiple steps, including growth of a primary tumor, intravasation, arrest and growth in a secondary site [2, 3]. The study of metastasis requires both a relevant mouse model and an appropriate tumor cell line. On the basis of gene profiling and previous in vivo results, rat mammary adenocarcinoma MTLn3 cells have been identified as a suitable model to study breast cancer progression and treatment [10, 11]. The epidermal growth factor receptor (EGFR, also referred as ErbB1) is often overexpressed in breast cancer, resulting not only in uncontrolled cell proliferation [12, 13] but also in increased tumor cell motility and invasion [14-16]. To study intravasation leading to metastasis formation, we therefore evaluated the effect of enhanced ErbB1 signaling in MTLn3 cells in the orthotopic Rag mouse breast cancer model.
###end p 8
###begin p 9
###xml 154 156 154 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR14">14</xref>
Efficient metastasis formation is dependent on tumor cell autonomous biological programs that define migration, intravasation survival and extravasation [14]. For xenotransplantation models, immune cell responses to foreign antigens on the injected tumor cells need to be avoided, necessitating the use immunocompromised hosts.
###end p 9
###begin p 10
###xml 215 217 215 217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR17">17</xref>
###xml 440 442 440 442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR18">18</xref>
###xml 443 445 443 445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR25">25</xref>
###xml 724 726 724 726 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR26">26</xref>
###xml 728 730 728 730 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR27">27</xref>
###xml 37 41 <span type="species:ncbi:10090">mice</span>
###xml 108 112 <span type="species:ncbi:10090">mice</span>
###xml 552 556 <span type="species:ncbi:10116">rats</span>
The most widely used immunodeficient mice (nude and SCID) lack the adaptive immune response. However, these mice still harbor large numbers of cells of the innate immune system, including natural killer (NK) cells [17]. These cells are important in the killing of viable circulating tumor cells that, through enhanced invasion and intravasation programs, have efficiently escape the primary tumor and have the potential to form metastasis [18-25]. Indeed, we showed previously that the MTLn3 cells are killed by the circulating NK-cells in Fischer 344 rats, thus preventing efficient lung metastasis formation. Although pretreatment with NK-depleting antibodies allowed experimental lung metastasis formation in this model [26, 27], continuous NK depleting antibody injection is an undesirable requirement for a breast/tumor metastasis model. To study breast tumor progression and metastasis formation using MTLn3 cells expressing the EGF receptor, an appropriate animal model with a compromised innate and adaptive immune system was still required.
###end p 10
###begin p 11
###xml 365 368 365 368 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 375 378 371 374 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 469 472 465 468 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 479 482 471 474 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 379 383 <span type="species:ncbi:10090">mice</span>
###xml 435 440 <span type="species:ncbi:10090">mouse</span>
###xml 483 487 <span type="species:ncbi:10090">mice</span>
The goal of the current study was to develop an MTLn3 cell breast tumor metastasis animal model that allows the unbiased analysis of tumor cell-dependent metastasis programs, independent of adaptive and innate immune system surveillance. We first show that increased expression of the ErbB1 receptor in MTLn3 cells was required for lung metastasis formation in Rag2-/- gammac-/- mice. Secondly, by comparing different immune deficient mouse models, we confirm that Rag2-/- gammac-/- mice, which lack NK cells, are an ideal recipient animal model for MTLn3 and 4T1 cells to study the metastasis process. In conclusion, we have established an improved animal model that can be used to study the biological steps that are essential in the formation of distant metastasis.
###end p 11
###begin title 12
Materials and methods
###end title 12
###begin title 13
Cell lines
###end title 13
###begin p 14
###xml 40 42 40 42 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR28">28</xref>
###xml 83 85 83 85 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR29">29</xref>
###xml 156 158 156 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR16">16</xref>
###xml 6 9 <span type="species:ncbi:10116">rat</span>
###xml 263 269 <span type="species:ncbi:9913">bovine</span>
###xml 301 306 <span type="species:ncbi:10090">mouse</span>
###xml 437 443 <span type="species:ncbi:9913">bovine</span>
MTLn3 rat mammary adenocarcinoma cells [28] were cultured as previously described [29]. MTLn3-GFP-ErbB1 and MTLn3-GFP cell-lines were previously described [16] and were maintained in alphaMEM (Life Technologies, Inc., Gaithersburg, MD) supplemented with 5% fetal bovine serum (Life Technologies). The mouse mammary metastatic 4T1-luc cell-line was purchased from Caliper Lifescience and cultured in RPMI-1640 supplemented with 10% fetal bovine serum (Life Technologies).
###end p 14
###begin title 15
Reagents
###end title 15
###begin p 16
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
###xml 11 16 <span type="species:ncbi:9606">human</span>
###xml 95 101 <span type="species:ncbi:9986">Rabbit</span>
###xml 107 112 <span type="species:ncbi:9606">human</span>
###xml 203 207 <span type="species:ncbi:9925">Goat</span>
###xml 213 218 <span type="species:ncbi:10090">mouse</span>
###xml 326 332 <span type="species:ncbi:9913">Bovine</span>
Mouse anti-human ErbB1 was purchased from Calbiochem (EMD Biosciences, San Diego, California). Rabbit anti-human ErbB1 used for immunoblotting was purchased from Cell Signaling Technology (Danvers, MA). Goat anti-mouse APC was purchased from Cedarlane (Ontario, Canada). Alpha modified minimal essential medium (a-MEM), Fetal Bovine Serum (FBS), phosphate buffered saline (PBS) and trypsin were from Life Technologies (Rockville, MD, USA).
###end p 16
###begin title 17
ErbB1 staining
###end title 17
###begin title 18
Flow cytometry
###end title 18
###begin p 19
###xml 175 179 <span type="species:ncbi:9925">goat</span>
###xml 185 190 <span type="species:ncbi:10090">mouse</span>
MTLn3 were harvested and incubated for 45 min with 50 mul of mAb ErbB1 (2 mug/ml in PBS). Cells were washed with cold PBS and incubated for 45 min with the secondary antibody goat-anti mouse APC in PBS (2 mug/ml). Finally, cells were washed and suspended in 0.3 ml PBS. ErbB1 and GFP expression were analysed by flow cytometry (FACScalibur, Becton Dickinson).
###end p 19
###begin title 20
Immunoblotting
###end title 20
###begin p 21
###xml 457 463 <span type="species:ncbi:9913">bovine</span>
###xml 648 659 <span type="species:ncbi:3704">horseradish</span>
Cells were scraped in ice-cold TSE (10 nM Tris-HCl, 250 mM sucrose, 1 mM EGTA, pH 7.4) supplemented with inhibitors. After sonication of either cells or tissue, protein concentrations were determined by the Bio-Rad (Hercules, CA) protein assay using IgG as a standard. Equal amounts of total cellular protein were separated by 7.5% SDS-PAGE and transferred to polyvinylidene difluoride membranes (Millipore, Billerica, MA). Blots were blocked with 5% (w/v) bovine serum albumin in TBST [0.5 mol/l NaCl, 20 mmol/l Tris-HCl, 0.05% (v/v) Tween 20 (pH 7.4)] and probed with primary antibody (overnight, 4degreesC) followed by incubation with secondary horseradish peroxidase-coupled antibody and visualized with Enhanced Chemiluminescence Plus reagent (Amersham Biosciences, Uppsala, Sweden) by scanning on a multilabel Typhoon imager 9400 (Amersham Biosciences).
###end p 21
###begin title 22
Animals
###end title 22
###begin p 23
###xml 41 45 41 45 <sup xmlns:xlink="http://www.w3.org/1999/xlink">scid</sup>
###xml 84 88 84 88 <sup xmlns:xlink="http://www.w3.org/1999/xlink">scid</sup>
###xml 93 95 93 95 <sup xmlns:xlink="http://www.w3.org/1999/xlink">bg</sup>
###xml 296 299 296 299 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 306 309 302 305 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 101 105 <span type="species:ncbi:10090">mice</span>
###xml 196 200 <span type="species:ncbi:10090">mice</span>
###xml 310 314 <span type="species:ncbi:10090">mice</span>
###xml 448 452 <span type="species:ncbi:10090">mice</span>
Female BALB/c nu/nu, SCID [CB17/lcr-Prkdcscid/Crl] and SCID Beige [CB17/lcr.Cg-Prkdcscid Lystbg/Crl] mice aged between 6 and 7 weeks were purchased from Charles River (L'Arbresle, France). BALB/c mice aged between 6 and 7 weeks were purchased from Janvier (Uden, The Netherlands). 6-week old Rag2-/- gammac-/- mice were obtained from in house breeding. Animals were housed in individually ventilated cages under sterile conditions containing three mice per cage. Sterilised food and water were provided ad libitum.
###end p 23
###begin title 24
Spontaneous and experimental metastasis assays
###end title 24
###begin p 25
###xml 134 135 134 135 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5</sup>
###xml 159 160 159 160 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5</sup>
###xml 325 327 324 326 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 334 336 333 335 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 462 463 461 462 <italic xmlns:xlink="http://www.w3.org/1999/xlink">h</italic>
###xml 479 480 478 479 <italic xmlns:xlink="http://www.w3.org/1999/xlink">v</italic>
###xml 527 528 526 527 <italic xmlns:xlink="http://www.w3.org/1999/xlink">V</italic>
###xml 546 547 545 546 <italic xmlns:xlink="http://www.w3.org/1999/xlink">V</italic>
###xml 568 569 560 561 <italic xmlns:xlink="http://www.w3.org/1999/xlink">h</italic>
###xml 572 573 564 565 <italic xmlns:xlink="http://www.w3.org/1999/xlink">v</italic>
###xml 575 576 567 568 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 250 255 <span type="species:ncbi:10090">mouse</span>
To measure spontaneous metastasis, tumor cells were grown to 70-85% confluence before being harvested for cell counting. Cells (5 x 105 for the MTLn3 or 1 x 105 for the 4T1-luc) were injected into the right thoracic mammary fat pads of the different mouse strains. Cells were injected in a volume of 100 mul of PBS without Ca2+ and Mg2+ through a 25-gauge needle. Tumor growth rate was monitored at weekly intervals after inoculation of tumor cells. Horizontal (h) and vertical (v) diameters were determined, and tumor volume (V) was calculated (V = 4/3pi(1/2[radical(h x v)]3). After 3 or 4 weeks, the animals were anesthetized with pentobarbital and the lungs were excised and rinsed in ice-cold PBS. For the GFP-labeled MTLn3 cell-lines, the right lung was used to count the tumor burden. For rough estimation, the right lungs were imaged with the Fluorescent imaging unit IVIS (see below). And for detailed quantification, the flat side of the right lung was analysed with the immunofluorescence microscope. With a x10 objective lens, we screened the flat surface of the lobe and counted the number of GFP positive metastases. Subsequently, the right lung was fixed in 4% paraformaldehyde. The left lung was injected with ink solution, de-stained in water and fixed in Fekete's (4.3% (v/v) acetic acid, 0.35% (v/v) formaldehyde in 70% ethanol). For the 4T1-luc cell-line, the lung tumor burden was quantified by counting the number of surface metastases which were represented by white spots on the ink-injected left lung.
###end p 25
###begin p 26
###xml 50 51 50 51 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5</sup>
###xml 137 140 137 140 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 147 150 143 146 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 151 155 <span type="species:ncbi:10090">mice</span>
###xml 198 202 <span type="species:ncbi:10090">mice</span>
For the experimental lung metastasis assay, 2 x 105 MTLn3 cells were injected into the lateral tail veins of 5- to 7-week-old female Rag2-/- gammac-/- mice. Three to four weeks after injection, the mice were euthanized, and the lungs were removed and subjected to fluorescent imaging and histologic examination as described below.
###end p 26
###begin title 27
Fluorescent imaging
###end title 27
###begin p 28
###xml 255 258 246 247 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#174;</sup>
Fluorescent imaging (FLI) was performed with a high sensitivity, cooled CCD camera mounted in a light-tight specimen box (IVIStrade mark; Xenogen). Imaging and quantification of signals were controlled by the acquisition and analysis software Living Image(R) (Xenogen). For ex vivo imaging, lungs were excised, placed into a petri dish, and imaged for 1-2 min. Tissues were subsequently fixed as above and prepared for standard histopathology evaluation.
###end p 28
###begin title 29
Measurement of tumor cell blood burden
###end title 29
###begin p 30
###xml 60 64 <span type="species:ncbi:10090">mice</span>
###xml 428 434 <span type="species:ncbi:9913">bovine</span>
At the end point of the MTLn3 spontaneous metastasis assay, mice were sacrificed with Nembutal. The right side of the thoracic cavity was exposed by a simple skin flap surgery. Blood was taken from the right atrium via heart puncture with a 25-gauge needle and 1-ml syringe coated with heparin. Blood (0.2-1.0 ml) was harvested from each animal. The blood was immediately plated into 100-mm-diameter dishes filled with 5% fetal bovine serum/alphaMEM growth medium. The next day, the plates were rinsed with fresh medium containing 0.8 mg/ml geneticin to selectively grow the tumor cells. After 3-7 days, all dishes were scanned for GFP expression with a Typhoon imager 9400 (Amersham Biosciences). The tumor cell clones were counted by image analysis of the obtained scans. Tumor blood burden was calculated as total colonies in the dish divided by the volume of blood taken.
###end p 30
###begin title 31
Tumor histology and quantitative assessment of the efficiency of metastasis
###end title 31
###begin p 32
###xml 39 44 <span type="species:ncbi:10090">mouse</span>
The primary tumors and lungs from each mouse were used for histological analysis. Samples were fixed in formalin and embedded in paraffin, and 5-mum sections were stained with H&E.
###end p 32
###begin title 33
Statistical analysis
###end title 33
###begin p 34
###xml 10 11 10 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 96 97 96 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
Student's t test was used to determine if there was a significant difference between two means (P < 0.05). Values are presented as mean +/- SD. Significant differences are marked in the graphs.
###end p 34
###begin title 35
Results
###end title 35
###begin title 36
###xml 119 122 119 122 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 129 132 125 128 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 133 137 <span type="species:ncbi:10090">mice</span>
ErbB1 overexpression in MTLn3 cells delays tumor growth but facilitates breast cancer lung metastasis formation in Rag2-/- gammac-/- mice
###end title 36
###begin p 37
###xml 77 79 77 79 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR12">12</xref>
###xml 81 83 81 83 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR13">13</xref>
###xml 478 479 478 479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig1" ref-type="fig">1</xref>
###xml 506 507 506 507 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig1" ref-type="fig">1</xref>
###xml 585 586 585 586 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig1" ref-type="fig">1</xref>
###xml 873 876 873 876 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 883 886 879 882 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1095 1096 1091 1092 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig1" ref-type="fig">1</xref>
###xml 1307 1308 1303 1304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig1" ref-type="fig">1</xref>
###xml 1504 1505 1500 1501 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig2" ref-type="fig">2</xref>
###xml 1552 1553 1548 1549 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig2" ref-type="fig">2</xref>
###xml 1659 1660 1655 1656 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig2" ref-type="fig">2</xref>
###xml 1814 1815 1810 1811 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig2" ref-type="fig">2</xref>
###xml 1903 1904 1899 1900 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig2" ref-type="fig">2</xref>
###xml 2698 2704 2694 2700 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;1</label>
###xml 2796 2797 2792 2793 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 2876 2877 2872 2873 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 2915 2919 2911 2915 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FACS</italic>
###xml 3051 3052 3047 3048 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 3172 3173 3168 3169 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 3201 3202 3197 3198 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 3247 3248 3243 3244 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 3260 3261 3256 3257 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d</bold>
###xml 3337 3338 3333 3334 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 2704 3346 2700 3342 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="38">ErbB1 over-expression affects tumor growth rate of MTLn3 in a spontaneous metastasis assay. <bold>a</bold> Western blot of ErbB1 expression in MTln3-GFP and MTLn3-GFP-ErbB1 cell-lines. <bold>b</bold> Fluorescence-activated cell sorting (<italic>FACS</italic>) analysis of cell surface expression levels of human ErbB1 and GFP expression levels for MTLn3-GFP and MTLn3-GFP-ErbB1 cell-lines. <bold>c</bold> Primary tumor growth measured by caliper during spontaneous metastasis assay. Rag mice were inoculated with MTLn3-GFP (<italic>n</italic>&#160;=&#160;13) and MTLn3-GFP-ErbB1 (<italic>n</italic>&#160;=&#160;17) cells (MTln3-GFP-ErbB1 vs. MTLn3-GFP, <italic>P</italic>&#160;&lt;&#160;0.0001). <bold>d</bold> Primary tumor weight at the end point of the spontaneous metastasis assay (<italic>P</italic>&#160;&gt;&#160;0.05)</p>
###xml 2704 3346 2700 3342 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="38">ErbB1 over-expression affects tumor growth rate of MTLn3 in a spontaneous metastasis assay. <bold>a</bold> Western blot of ErbB1 expression in MTln3-GFP and MTLn3-GFP-ErbB1 cell-lines. <bold>b</bold> Fluorescence-activated cell sorting (<italic>FACS</italic>) analysis of cell surface expression levels of human ErbB1 and GFP expression levels for MTLn3-GFP and MTLn3-GFP-ErbB1 cell-lines. <bold>c</bold> Primary tumor growth measured by caliper during spontaneous metastasis assay. Rag mice were inoculated with MTLn3-GFP (<italic>n</italic>&#160;=&#160;13) and MTLn3-GFP-ErbB1 (<italic>n</italic>&#160;=&#160;17) cells (MTln3-GFP-ErbB1 vs. MTLn3-GFP, <italic>P</italic>&#160;&lt;&#160;0.0001). <bold>d</bold> Primary tumor weight at the end point of the spontaneous metastasis assay (<italic>P</italic>&#160;&gt;&#160;0.05)</p></caption>
###xml 3346 3346 3342 3342 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="10585_2009_9267_Fig1_HTML" id="MO1"/>
###xml 2698 3346 2694 3342 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig1"><label>Fig.&#160;1</label><caption><p textid="38">ErbB1 over-expression affects tumor growth rate of MTLn3 in a spontaneous metastasis assay. <bold>a</bold> Western blot of ErbB1 expression in MTln3-GFP and MTLn3-GFP-ErbB1 cell-lines. <bold>b</bold> Fluorescence-activated cell sorting (<italic>FACS</italic>) analysis of cell surface expression levels of human ErbB1 and GFP expression levels for MTLn3-GFP and MTLn3-GFP-ErbB1 cell-lines. <bold>c</bold> Primary tumor growth measured by caliper during spontaneous metastasis assay. Rag mice were inoculated with MTLn3-GFP (<italic>n</italic>&#160;=&#160;13) and MTLn3-GFP-ErbB1 (<italic>n</italic>&#160;=&#160;17) cells (MTln3-GFP-ErbB1 vs. MTLn3-GFP, <italic>P</italic>&#160;&lt;&#160;0.0001). <bold>d</bold> Primary tumor weight at the end point of the spontaneous metastasis assay (<italic>P</italic>&#160;&gt;&#160;0.05)</p></caption><graphic position="anchor" xlink:href="10585_2009_9267_Fig1_HTML" id="MO1"/></fig>
###xml 3346 3352 3342 3348 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;2</label>
###xml 3452 3453 3448 3449 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 3551 3560 3547 3556 <italic xmlns:xlink="http://www.w3.org/1999/xlink">left lung</italic>
###xml 3650 3651 3646 3647 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 3663 3664 3659 3660 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 3806 3807 3802 3803 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 3850 3860 3846 3856 <italic xmlns:xlink="http://www.w3.org/1999/xlink">left panel</italic>
###xml 3889 3900 3885 3896 <italic xmlns:xlink="http://www.w3.org/1999/xlink">right panel</italic>
###xml 3917 3918 3913 3914 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d</bold>
###xml 4004 4005 4000 4001 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 3352 4011 3348 4007 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="39">ErbB1 over-expression significantly enhances lung metastasis formation independent of tumor weight. <bold>a</bold> Lung metastases counted with a fluorescent microscope at &#215;10 magnification (only one side of the <italic>left lung</italic>) at the end point of the spontaneous metastasis assay (MTln3-GFP-ErbB1 versus MTLn3-GFP, <italic>P</italic>&#160;&lt;&#160;0.0001). <bold>b</bold> Lung metastases visualized with the FLI (GFP detection) after spontaneous metastasis assay with the MTLn3-GFP and the MTLn3-GFP-ErbB1 cells. <bold>c</bold> H&amp;E staining of lung tissue of MTLn3-GFP (<italic>left panel</italic>) and MTLn3-GFP-ErbB1 cells (<italic>right panel</italic>) injected mice. <bold>d</bold> Lung metastases plotted against tumor weight of MTLn3-GFP-ErbB1 tumors bearing mice (<italic>n</italic>&#160;=&#160;17)</p>
###xml 3352 4011 3348 4007 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="39">ErbB1 over-expression significantly enhances lung metastasis formation independent of tumor weight. <bold>a</bold> Lung metastases counted with a fluorescent microscope at &#215;10 magnification (only one side of the <italic>left lung</italic>) at the end point of the spontaneous metastasis assay (MTln3-GFP-ErbB1 versus MTLn3-GFP, <italic>P</italic>&#160;&lt;&#160;0.0001). <bold>b</bold> Lung metastases visualized with the FLI (GFP detection) after spontaneous metastasis assay with the MTLn3-GFP and the MTLn3-GFP-ErbB1 cells. <bold>c</bold> H&amp;E staining of lung tissue of MTLn3-GFP (<italic>left panel</italic>) and MTLn3-GFP-ErbB1 cells (<italic>right panel</italic>) injected mice. <bold>d</bold> Lung metastases plotted against tumor weight of MTLn3-GFP-ErbB1 tumors bearing mice (<italic>n</italic>&#160;=&#160;17)</p></caption>
###xml 4011 4011 4007 4007 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="10585_2009_9267_Fig2_HTML" id="MO2"/>
###xml 3346 4011 3342 4007 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig2"><label>Fig.&#160;2</label><caption><p textid="39">ErbB1 over-expression significantly enhances lung metastasis formation independent of tumor weight. <bold>a</bold> Lung metastases counted with a fluorescent microscope at &#215;10 magnification (only one side of the <italic>left lung</italic>) at the end point of the spontaneous metastasis assay (MTln3-GFP-ErbB1 versus MTLn3-GFP, <italic>P</italic>&#160;&lt;&#160;0.0001). <bold>b</bold> Lung metastases visualized with the FLI (GFP detection) after spontaneous metastasis assay with the MTLn3-GFP and the MTLn3-GFP-ErbB1 cells. <bold>c</bold> H&amp;E staining of lung tissue of MTLn3-GFP (<italic>left panel</italic>) and MTLn3-GFP-ErbB1 cells (<italic>right panel</italic>) injected mice. <bold>d</bold> Lung metastases plotted against tumor weight of MTLn3-GFP-ErbB1 tumors bearing mice (<italic>n</italic>&#160;=&#160;17)</p></caption><graphic position="anchor" xlink:href="10585_2009_9267_Fig2_HTML" id="MO2"/></fig>
###xml 289 294 <span type="species:ncbi:10090">mouse</span>
###xml 887 891 <span type="species:ncbi:10090">mice</span>
###xml 1376 1380 <span type="species:ncbi:10090">Mice</span>
###xml 1462 1466 <span type="species:ncbi:10090">mice</span>
###xml 1680 1684 <span type="species:ncbi:10090">mice</span>
###xml 1964 1968 <span type="species:ncbi:10090">mice</span>
###xml 2498 2502 <span type="species:ncbi:10090">mice</span>
###xml 2693 2697 <span type="species:ncbi:10090">mice</span>
###xml 2967 2972 <span type="species:ncbi:9606">human</span>
###xml 3135 3139 <span type="species:ncbi:10090">mice</span>
###xml 3911 3915 <span type="species:ncbi:10090">mice</span>
###xml 3998 4002 <span type="species:ncbi:10090">mice</span>
Since the EGF receptor is often over expressed in breast cancer progression [12, 13], we used MTLn3-GFP-ErbB1 cells, because of the high likelihood of success for metastasis formation. First, we verified whether ErbB1 overexpression is indeed essential for metastases formation in the Rag mouse model. Therefore we compared MTLn3-GFP with MTLn3-GFP-ErbB1 cells. Increased expression of ErbB1 protein in the MTLn3-GFP-ErbB1 cell-line was confirmed by Western blot analysis (Fig. 1a) and flow cytometry (Fig 1b). We also confirmed that GFP was equally expressed in both cell-lines (Fig. 1b). The expression of GFP was used to count the lung metastases and detect the tumor cells in blood. To determine the effects of increased ErbB1 expression on tumor growth and metastasis, MTLn3-GFP-ErbB1 and the control cell-line MTLn3-GFP were injected into the mammary fat pads of Rag2-/- gammac-/- mice, and tumor growth was monitored. All animals implanted with tumor cells developed tumors at the site of injection. The tumor growth of MTLn3-GFP cells was faster than that of MTln3-GFP-ErbB1 cells (Fig. 1c). Animals were sacrificed when the primary tumor reached similar volume for the two cell-lines between day 25 and 30. Indeed, there was no significant difference in tumor weight at the time of sacrifice (Fig. 1d). The animals were checked for spontaneous metastasis efficiency. Mice implanted with MTLn3-GFP-ErbB1 cells had significantly more lung metastases than mice implanted with MTLn3-GFP cells (Fig. 2a) also evidence by fluorescence imaging (Fig. 2b). Histological analysis of the lungs showed an absence of micro-metastases in the MTLn3-GFP group (Fig. 2c). In the lungs of mice implanted with MTLn3-GFP-ErbB1 cells, many macro-metastases could be detected on the surface and also throughout the lungs (Fig. 2c). No correlation was founded between tumor weight and number of lung metastases (Fig. 2d). We considered whether the additional period allowed for mice with delayed tumor growth could account for the increased number of lung metastases in the MTLn3-GFP-ErbB1 group. Therefore, we performed an experiment where both groups were sacrificed after 25 days. The primary tumors of the MTLn3-GFP-ErbB1 group again showed reduced growth rate (supplementary data Fig. 2a) and tumor weight was much lower than the MTLn3-GFP tumors (supplementary data Fig. 2b). Despite this reduced tumor growth, there was a trend toward a greater number of lung metastases in ErbB1-expressing tumor bearing mice (supplementary data Fig. 2c). We conclude from these results that increased expression of ErbB1 in MTLn3 cells results in reduced tumor growth but increased number of lung metastasis in Rag mice.Fig. 1ErbB1 over-expression affects tumor growth rate of MTLn3 in a spontaneous metastasis assay. a Western blot of ErbB1 expression in MTln3-GFP and MTLn3-GFP-ErbB1 cell-lines. b Fluorescence-activated cell sorting (FACS) analysis of cell surface expression levels of human ErbB1 and GFP expression levels for MTLn3-GFP and MTLn3-GFP-ErbB1 cell-lines. c Primary tumor growth measured by caliper during spontaneous metastasis assay. Rag mice were inoculated with MTLn3-GFP (n = 13) and MTLn3-GFP-ErbB1 (n = 17) cells (MTln3-GFP-ErbB1 vs. MTLn3-GFP, P < 0.0001). d Primary tumor weight at the end point of the spontaneous metastasis assay (P > 0.05)Fig. 2ErbB1 over-expression significantly enhances lung metastasis formation independent of tumor weight. a Lung metastases counted with a fluorescent microscope at x10 magnification (only one side of the left lung) at the end point of the spontaneous metastasis assay (MTln3-GFP-ErbB1 versus MTLn3-GFP, P < 0.0001). b Lung metastases visualized with the FLI (GFP detection) after spontaneous metastasis assay with the MTLn3-GFP and the MTLn3-GFP-ErbB1 cells. c H&E staining of lung tissue of MTLn3-GFP (left panel) and MTLn3-GFP-ErbB1 cells (right panel) injected mice. d Lung metastases plotted against tumor weight of MTLn3-GFP-ErbB1 tumors bearing mice (n = 17)
###end p 37
###begin p 38
###xml 92 93 92 93 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 172 173 172 173 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 211 215 211 215 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FACS</italic>
###xml 347 348 347 348 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 468 469 468 469 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 497 498 497 498 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 543 544 543 544 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 556 557 556 557 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d</bold>
###xml 633 634 633 634 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 263 268 <span type="species:ncbi:9606">human</span>
###xml 431 435 <span type="species:ncbi:10090">mice</span>
ErbB1 over-expression affects tumor growth rate of MTLn3 in a spontaneous metastasis assay. a Western blot of ErbB1 expression in MTln3-GFP and MTLn3-GFP-ErbB1 cell-lines. b Fluorescence-activated cell sorting (FACS) analysis of cell surface expression levels of human ErbB1 and GFP expression levels for MTLn3-GFP and MTLn3-GFP-ErbB1 cell-lines. c Primary tumor growth measured by caliper during spontaneous metastasis assay. Rag mice were inoculated with MTLn3-GFP (n = 13) and MTLn3-GFP-ErbB1 (n = 17) cells (MTln3-GFP-ErbB1 vs. MTLn3-GFP, P < 0.0001). d Primary tumor weight at the end point of the spontaneous metastasis assay (P > 0.05)
###end p 38
###begin p 39
###xml 100 101 100 101 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 199 208 199 208 <italic xmlns:xlink="http://www.w3.org/1999/xlink">left lung</italic>
###xml 298 299 298 299 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 311 312 311 312 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 454 455 454 455 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 498 508 498 508 <italic xmlns:xlink="http://www.w3.org/1999/xlink">left panel</italic>
###xml 537 548 537 548 <italic xmlns:xlink="http://www.w3.org/1999/xlink">right panel</italic>
###xml 565 566 565 566 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d</bold>
###xml 652 653 652 653 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 559 563 <span type="species:ncbi:10090">mice</span>
###xml 646 650 <span type="species:ncbi:10090">mice</span>
ErbB1 over-expression significantly enhances lung metastasis formation independent of tumor weight. a Lung metastases counted with a fluorescent microscope at x10 magnification (only one side of the left lung) at the end point of the spontaneous metastasis assay (MTln3-GFP-ErbB1 versus MTLn3-GFP, P < 0.0001). b Lung metastases visualized with the FLI (GFP detection) after spontaneous metastasis assay with the MTLn3-GFP and the MTLn3-GFP-ErbB1 cells. c H&E staining of lung tissue of MTLn3-GFP (left panel) and MTLn3-GFP-ErbB1 cells (right panel) injected mice. d Lung metastases plotted against tumor weight of MTLn3-GFP-ErbB1 tumors bearing mice (n = 17)
###end p 39
###begin title 40
###xml 35 38 35 38 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 45 48 41 44 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 49 53 <span type="species:ncbi:10090">mice</span>
ErbB1-driven metastasis in the Rag2-/- gammac-/- mice is dependent on enhanced intravasation in the primary tumor
###end title 40
###begin p 41
###xml 443 444 443 444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig3" ref-type="fig">3</xref>
###xml 575 578 575 578 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 585 588 581 584 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 594 600 590 596 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;3</label>
###xml 724 725 720 721 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 931 940 927 936 <italic xmlns:xlink="http://www.w3.org/1999/xlink">left side</italic>
###xml 985 995 981 991 <italic xmlns:xlink="http://www.w3.org/1999/xlink">right side</italic>
###xml 998 999 994 995 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 1154 1155 1150 1151 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1165 1166 1161 1162 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 1264 1273 1260 1269 <italic xmlns:xlink="http://www.w3.org/1999/xlink">left lung</italic>
###xml 1394 1395 1390 1391 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1405 1406 1401 1402 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d</bold>
###xml 600 1524 596 1520 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="42">ErbB1-driven metastasis is due to enhanced intravasation ability and not due to enhanced growth of metastases in the lungs. <bold>a</bold> Scan with Typhoon imager of two dishes where approximately 0.7&#160;ml of blood directly drawn from the right ventricle was cultured for 7&#160;days. GFP colonies of blood collected from MTLn3-GFP inoculated mouse (<italic>left side</italic>) and from MTLn3-GFP-ErbB1 inoculated mouse (<italic>right side</italic>). <bold>b</bold> Tumor blood burden at the end point of the spontaneous metastasis assay. Colonies were counted after 7&#160;days of culture (MTLn3-GFP versus MTLn3-GFP-ErbB1, <italic>P</italic>&#160;&lt;&#160;0.05). <bold>c</bold> Lung metastases counted with a fluorescent microscope at &#215;10 magnification (only one side of the <italic>left lung</italic>) at the end point (day 28) of the experimental metastasis assays (tail vein MTLn3-GFP versus tail vein MTLn3-GFP-ErbB1, <italic>P</italic>&#160;&gt;&#160;0.05). <bold>d</bold> Lung metastases visualized with FLI after experimental metastasis assay with MTLn3-GFP and MTLn3-GFP-ErbB1 cells only</p>
###xml 600 1524 596 1520 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="42">ErbB1-driven metastasis is due to enhanced intravasation ability and not due to enhanced growth of metastases in the lungs. <bold>a</bold> Scan with Typhoon imager of two dishes where approximately 0.7&#160;ml of blood directly drawn from the right ventricle was cultured for 7&#160;days. GFP colonies of blood collected from MTLn3-GFP inoculated mouse (<italic>left side</italic>) and from MTLn3-GFP-ErbB1 inoculated mouse (<italic>right side</italic>). <bold>b</bold> Tumor blood burden at the end point of the spontaneous metastasis assay. Colonies were counted after 7&#160;days of culture (MTLn3-GFP versus MTLn3-GFP-ErbB1, <italic>P</italic>&#160;&lt;&#160;0.05). <bold>c</bold> Lung metastases counted with a fluorescent microscope at &#215;10 magnification (only one side of the <italic>left lung</italic>) at the end point (day 28) of the experimental metastasis assays (tail vein MTLn3-GFP versus tail vein MTLn3-GFP-ErbB1, <italic>P</italic>&#160;&gt;&#160;0.05). <bold>d</bold> Lung metastases visualized with FLI after experimental metastasis assay with MTLn3-GFP and MTLn3-GFP-ErbB1 cells only</p></caption>
###xml 1524 1524 1520 1520 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="10585_2009_9267_Fig3_HTML" id="MO3"/>
###xml 594 1524 590 1520 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig3"><label>Fig.&#160;3</label><caption><p textid="42">ErbB1-driven metastasis is due to enhanced intravasation ability and not due to enhanced growth of metastases in the lungs. <bold>a</bold> Scan with Typhoon imager of two dishes where approximately 0.7&#160;ml of blood directly drawn from the right ventricle was cultured for 7&#160;days. GFP colonies of blood collected from MTLn3-GFP inoculated mouse (<italic>left side</italic>) and from MTLn3-GFP-ErbB1 inoculated mouse (<italic>right side</italic>). <bold>b</bold> Tumor blood burden at the end point of the spontaneous metastasis assay. Colonies were counted after 7&#160;days of culture (MTLn3-GFP versus MTLn3-GFP-ErbB1, <italic>P</italic>&#160;&lt;&#160;0.05). <bold>c</bold> Lung metastases counted with a fluorescent microscope at &#215;10 magnification (only one side of the <italic>left lung</italic>) at the end point (day 28) of the experimental metastasis assays (tail vein MTLn3-GFP versus tail vein MTLn3-GFP-ErbB1, <italic>P</italic>&#160;&gt;&#160;0.05). <bold>d</bold> Lung metastases visualized with FLI after experimental metastasis assay with MTLn3-GFP and MTLn3-GFP-ErbB1 cells only</p></caption><graphic position="anchor" xlink:href="10585_2009_9267_Fig3_HTML" id="MO3"/></fig>
###xml 589 593 <span type="species:ncbi:10090">mice</span>
###xml 924 929 <span type="species:ncbi:10090">mouse</span>
###xml 978 983 <span type="species:ncbi:10090">mouse</span>
Intravasation is a crucial step in the process of metastasis formation and ErbB1 signaling is thought to be a key factor in this process. Intravasation can be evaluated by determining the number of tumor cells present in blood collected from the right atrium of the heart. Animals bearing MTLn3-GFP tumors had very few tumor cells/ml of blood, whereas animals bearing MTLn3-GFP-ErbB1 tumors had an average of 170 tumor cells/ml of blood (Fig. 3a, b). In conclusion, increased ErbB1 expression in MTLn3 cells enhances intravasation and thereby metastasis formation in the Rag2-/- gammac-/- mice.Fig. 3ErbB1-driven metastasis is due to enhanced intravasation ability and not due to enhanced growth of metastases in the lungs. a Scan with Typhoon imager of two dishes where approximately 0.7 ml of blood directly drawn from the right ventricle was cultured for 7 days. GFP colonies of blood collected from MTLn3-GFP inoculated mouse (left side) and from MTLn3-GFP-ErbB1 inoculated mouse (right side). b Tumor blood burden at the end point of the spontaneous metastasis assay. Colonies were counted after 7 days of culture (MTLn3-GFP versus MTLn3-GFP-ErbB1, P < 0.05). c Lung metastases counted with a fluorescent microscope at x10 magnification (only one side of the left lung) at the end point (day 28) of the experimental metastasis assays (tail vein MTLn3-GFP versus tail vein MTLn3-GFP-ErbB1, P > 0.05). d Lung metastases visualized with FLI after experimental metastasis assay with MTLn3-GFP and MTLn3-GFP-ErbB1 cells only
###end p 41
###begin p 42
###xml 124 125 124 125 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 331 340 331 340 <italic xmlns:xlink="http://www.w3.org/1999/xlink">left side</italic>
###xml 385 395 385 395 <italic xmlns:xlink="http://www.w3.org/1999/xlink">right side</italic>
###xml 398 399 398 399 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 554 555 554 555 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 565 566 565 566 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 664 673 664 673 <italic xmlns:xlink="http://www.w3.org/1999/xlink">left lung</italic>
###xml 794 795 794 795 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 805 806 805 806 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d</bold>
###xml 324 329 <span type="species:ncbi:10090">mouse</span>
###xml 378 383 <span type="species:ncbi:10090">mouse</span>
ErbB1-driven metastasis is due to enhanced intravasation ability and not due to enhanced growth of metastases in the lungs. a Scan with Typhoon imager of two dishes where approximately 0.7 ml of blood directly drawn from the right ventricle was cultured for 7 days. GFP colonies of blood collected from MTLn3-GFP inoculated mouse (left side) and from MTLn3-GFP-ErbB1 inoculated mouse (right side). b Tumor blood burden at the end point of the spontaneous metastasis assay. Colonies were counted after 7 days of culture (MTLn3-GFP versus MTLn3-GFP-ErbB1, P < 0.05). c Lung metastases counted with a fluorescent microscope at x10 magnification (only one side of the left lung) at the end point (day 28) of the experimental metastasis assays (tail vein MTLn3-GFP versus tail vein MTLn3-GFP-ErbB1, P > 0.05). d Lung metastases visualized with FLI after experimental metastasis assay with MTLn3-GFP and MTLn3-GFP-ErbB1 cells only
###end p 42
###begin p 43
###xml 591 592 591 592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig1" ref-type="fig">1</xref>
###xml 594 595 594 595 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig2" ref-type="fig">2</xref>
###xml 739 740 739 740 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig3" ref-type="fig">3</xref>
###xml 344 348 <span type="species:ncbi:10090">mice</span>
###xml 378 382 <span type="species:ncbi:10090">mice</span>
Finally, we determined whether ErbB1-mediated enhanced lung metastasis was also related to increased homing, extravasation, or growth of the tumor cells in the lungs. For this purpose we compared the MTLn3-GFP and MTLn3-GFP-ErbB1 cell lung metastasis following injected into the lateral tail vein (200,000 cells) of 5- to 7-week-old female Rag mice. Four weeks after injection, mice were sacrificed, and the lungs were removed and examined for metastases. While in the spontaneous metastasis assay significantly more metastases were observed in the MTLn3-GFP-ErbB1 transplanted group (Figs. 1, 2), animals receiving MTLn3-GFP or MTLn3-GFP-ErbB1 cells in the tail vein developed a comparable number of metastatic lesions in the lungs (Fig. 3c, d). These results indicate that the enhanced ErbB1-dependent metastasis formation from the primary tumor is principally determined by intravasation and/or enhanced invasion rather than homing events at the target organ.
###end p 43
###begin title 44
NK cells do not interfere with primary tumor growth
###end title 44
###begin p 45
###xml 113 115 113 115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR27">27</xref>
###xml 370 372 370 372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR14">14</xref>
###xml 374 376 374 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR30">30</xref>
###xml 378 380 378 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR31">31</xref>
###xml 581 582 581 582 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab1" ref-type="table">1</xref>
###xml 773 774 773 774 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR6">6</xref>
###xml 776 778 776 778 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR18">18</xref>
###xml 780 782 780 782 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR20">20</xref>
###xml 783 785 783 785 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR23">23</xref>
###xml 787 789 787 789 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR25">25</xref>
###xml 791 793 791 793 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR32">32</xref>
###xml 800 803 800 803 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 810 813 806 809 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1151 1154 1139 1142 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1261 1262 1249 1250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR6">6</xref>
###xml 1264 1266 1252 1254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR32">32</xref>
###xml 1824 1825 1812 1813 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig4" ref-type="fig">4</xref>
###xml 1894 1895 1882 1883 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 1902 1903 1890 1891 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig4" ref-type="fig">4</xref>
###xml 1952 1953 1940 1941 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig4" ref-type="fig">4</xref>
###xml 2436 2443 2424 2431 <label xmlns:xlink="http://www.w3.org/1999/xlink">Table&#160;1</label>
###xml 2443 2487 2431 2475 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="46">Characteristics of immunodeficient mice used</p>
###xml 2443 2487 2431 2475 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="46">Characteristics of immunodeficient mice used</p></caption>
###xml 2487 2493 2475 2481 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Strain</th>
###xml 2493 2510 2481 2498 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Adaptive immunity</th>
###xml 2510 2525 2498 2513 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Innate immunity</th>
###xml 2525 2534 2513 2522 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Reference</th>
###xml 2487 2534 2475 2522 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th align="left">Strain</th><th align="left">Adaptive immunity</th><th align="left">Innate immunity</th><th align="left">Reference</th></tr>
###xml 2487 2534 2475 2522 <thead xmlns:xlink="http://www.w3.org/1999/xlink"><tr><th align="left">Strain</th><th align="left">Adaptive immunity</th><th align="left">Innate immunity</th><th align="left">Reference</th></tr></thead>
###xml 2534 2555 2522 2543 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">BALB/c nu/nu 6 [Nude]</td>
###xml 2555 2572 2543 2560 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">T cell deficiency</td>
###xml 2572 2572 2560 2560 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 2573 2575 2561 2563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR52">52</xref>
###xml 2572 2576 2560 2564 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">[<xref ref-type="bibr" rid="CR52">52</xref>]</td>
###xml 2534 2576 2522 2564 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">BALB/c nu/nu 6 [Nude]</td><td align="left">T cell deficiency</td><td align="left"/><td align="left">[<xref ref-type="bibr" rid="CR52">52</xref>]</td></tr>
###xml 2590 2594 2578 2582 <sup xmlns:xlink="http://www.w3.org/1999/xlink">SCID</sup>
###xml 2576 2605 2564 2593 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">CB17/lcr-Prkdc<sup>SCID</sup>/Crl [SCID]</td>
###xml 2605 2628 2593 2616 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">T and B cell deficiency</td>
###xml 2628 2628 2616 2616 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 2629 2631 2617 2619 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR53">53</xref>
###xml 2632 2634 2620 2622 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR55">55</xref>
###xml 2628 2635 2616 2623 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">[<xref ref-type="bibr" rid="CR53">53</xref>&#8211;<xref ref-type="bibr" rid="CR55">55</xref>]</td>
###xml 2576 2635 2564 2623 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">CB17/lcr-Prkdc<sup>SCID</sup>/Crl [SCID]</td><td align="left">T and B cell deficiency</td><td align="left"/><td align="left">[<xref ref-type="bibr" rid="CR53">53</xref>&#8211;<xref ref-type="bibr" rid="CR55">55</xref>]</td></tr>
###xml 2652 2656 2640 2644 <sup xmlns:xlink="http://www.w3.org/1999/xlink">SCID</sup>
###xml 2661 2663 2649 2651 <sup xmlns:xlink="http://www.w3.org/1999/xlink">bg</sup>
###xml 2635 2680 2623 2668 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">CB17/lcr.Cg-Prkdc<sup>SCID</sup> Lyst<sup>bg</sup>/Crl [SCID Beige]</td>
###xml 2680 2703 2668 2691 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">T and B cell deficiency</td>
###xml 2703 2727 2691 2715 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Reduced NK cell function</td>
###xml 2728 2730 2716 2718 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR35">35</xref>
###xml 2732 2734 2720 2722 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR36">36</xref>
###xml 2736 2738 2724 2726 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR56">56</xref>
###xml 2727 2739 2715 2727 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">[<xref ref-type="bibr" rid="CR35">35</xref>, <xref ref-type="bibr" rid="CR36">36</xref>, <xref ref-type="bibr" rid="CR56">56</xref>]</td>
###xml 2635 2739 2623 2727 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">CB17/lcr.Cg-Prkdc<sup>SCID</sup> Lyst<sup>bg</sup>/Crl [SCID Beige]</td><td align="left">T and B cell deficiency</td><td align="left">Reduced NK cell function</td><td align="left">[<xref ref-type="bibr" rid="CR35">35</xref>, <xref ref-type="bibr" rid="CR36">36</xref>, <xref ref-type="bibr" rid="CR56">56</xref>]</td></tr>
###xml 2743 2746 2731 2734 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 2753 2756 2737 2740 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 2739 2762 2727 2746 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Rag2<sup>&#8722;/&#8722;</sup> &#947;c<sup>&#8722;/&#8722;</sup> [Rag]</td>
###xml 2762 2785 2746 2769 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">T and B cell deficiency</td>
###xml 2785 2803 2769 2787 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">NK cell deficiency</td>
###xml 2804 2805 2788 2789 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR6">6</xref>
###xml 2807 2809 2791 2793 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR32">32</xref>
###xml 2811 2813 2795 2797 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR57">57</xref>
###xml 2815 2817 2799 2801 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR58">58</xref>
###xml 2803 2818 2787 2802 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">[<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR32">32</xref>, <xref ref-type="bibr" rid="CR57">57</xref>, <xref ref-type="bibr" rid="CR58">58</xref>]</td>
###xml 2739 2818 2727 2802 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Rag2<sup>&#8722;/&#8722;</sup> &#947;c<sup>&#8722;/&#8722;</sup> [Rag]</td><td align="left">T and B cell deficiency</td><td align="left">NK cell deficiency</td><td align="left">[<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR32">32</xref>, <xref ref-type="bibr" rid="CR57">57</xref>, <xref ref-type="bibr" rid="CR58">58</xref>]</td></tr>
###xml 2534 2818 2522 2802 <tbody xmlns:xlink="http://www.w3.org/1999/xlink"><tr><td align="left">BALB/c nu/nu 6 [Nude]</td><td align="left">T cell deficiency</td><td align="left"/><td align="left">[<xref ref-type="bibr" rid="CR52">52</xref>]</td></tr><tr><td align="left">CB17/lcr-Prkdc<sup>SCID</sup>/Crl [SCID]</td><td align="left">T and B cell deficiency</td><td align="left"/><td align="left">[<xref ref-type="bibr" rid="CR53">53</xref>&#8211;<xref ref-type="bibr" rid="CR55">55</xref>]</td></tr><tr><td align="left">CB17/lcr.Cg-Prkdc<sup>SCID</sup> Lyst<sup>bg</sup>/Crl [SCID Beige]</td><td align="left">T and B cell deficiency</td><td align="left">Reduced NK cell function</td><td align="left">[<xref ref-type="bibr" rid="CR35">35</xref>, <xref ref-type="bibr" rid="CR36">36</xref>, <xref ref-type="bibr" rid="CR56">56</xref>]</td></tr><tr><td align="left">Rag2<sup>&#8722;/&#8722;</sup> &#947;c<sup>&#8722;/&#8722;</sup> [Rag]</td><td align="left">T and B cell deficiency</td><td align="left">NK cell deficiency</td><td align="left">[<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR32">32</xref>, <xref ref-type="bibr" rid="CR57">57</xref>, <xref ref-type="bibr" rid="CR58">58</xref>]</td></tr></tbody>
###xml 2487 2818 2475 2802 <table xmlns:xlink="http://www.w3.org/1999/xlink" frame="hsides" rules="groups"><thead><tr><th align="left">Strain</th><th align="left">Adaptive immunity</th><th align="left">Innate immunity</th><th align="left">Reference</th></tr></thead><tbody><tr><td align="left">BALB/c nu/nu 6 [Nude]</td><td align="left">T cell deficiency</td><td align="left"/><td align="left">[<xref ref-type="bibr" rid="CR52">52</xref>]</td></tr><tr><td align="left">CB17/lcr-Prkdc<sup>SCID</sup>/Crl [SCID]</td><td align="left">T and B cell deficiency</td><td align="left"/><td align="left">[<xref ref-type="bibr" rid="CR53">53</xref>&#8211;<xref ref-type="bibr" rid="CR55">55</xref>]</td></tr><tr><td align="left">CB17/lcr.Cg-Prkdc<sup>SCID</sup> Lyst<sup>bg</sup>/Crl [SCID Beige]</td><td align="left">T and B cell deficiency</td><td align="left">Reduced NK cell function</td><td align="left">[<xref ref-type="bibr" rid="CR35">35</xref>, <xref ref-type="bibr" rid="CR36">36</xref>, <xref ref-type="bibr" rid="CR56">56</xref>]</td></tr><tr><td align="left">Rag2<sup>&#8722;/&#8722;</sup> &#947;c<sup>&#8722;/&#8722;</sup> [Rag]</td><td align="left">T and B cell deficiency</td><td align="left">NK cell deficiency</td><td align="left">[<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR32">32</xref>, <xref ref-type="bibr" rid="CR57">57</xref>, <xref ref-type="bibr" rid="CR58">58</xref>]</td></tr></tbody></table>
###xml 2436 2818 2424 2802 <table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" id="Tab1"><label>Table&#160;1</label><caption><p textid="46">Characteristics of immunodeficient mice used</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Strain</th><th align="left">Adaptive immunity</th><th align="left">Innate immunity</th><th align="left">Reference</th></tr></thead><tbody><tr><td align="left">BALB/c nu/nu 6 [Nude]</td><td align="left">T cell deficiency</td><td align="left"/><td align="left">[<xref ref-type="bibr" rid="CR52">52</xref>]</td></tr><tr><td align="left">CB17/lcr-Prkdc<sup>SCID</sup>/Crl [SCID]</td><td align="left">T and B cell deficiency</td><td align="left"/><td align="left">[<xref ref-type="bibr" rid="CR53">53</xref>&#8211;<xref ref-type="bibr" rid="CR55">55</xref>]</td></tr><tr><td align="left">CB17/lcr.Cg-Prkdc<sup>SCID</sup> Lyst<sup>bg</sup>/Crl [SCID Beige]</td><td align="left">T and B cell deficiency</td><td align="left">Reduced NK cell function</td><td align="left">[<xref ref-type="bibr" rid="CR35">35</xref>, <xref ref-type="bibr" rid="CR36">36</xref>, <xref ref-type="bibr" rid="CR56">56</xref>]</td></tr><tr><td align="left">Rag2<sup>&#8722;/&#8722;</sup> &#947;c<sup>&#8722;/&#8722;</sup> [Rag]</td><td align="left">T and B cell deficiency</td><td align="left">NK cell deficiency</td><td align="left">[<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR32">32</xref>, <xref ref-type="bibr" rid="CR57">57</xref>, <xref ref-type="bibr" rid="CR58">58</xref>]</td></tr></tbody></table></table-wrap>
###xml 2818 2824 2802 2808 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;4</label>
###xml 2907 2910 2891 2894 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 2917 2920 2897 2900 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 2927 2928 2907 2908 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 2970 2971 2950 2951 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 2984 2985 2964 2965 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 3004 3005 2984 2985 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 3019 3022 2999 3002 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 3029 3032 3005 3008 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 3034 3035 3010 3011 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 3110 3111 3086 3087 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 3187 3188 3163 3164 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 2824 3196 2808 3172 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="47">MTLn3-GFP-ErbB1 cells have a similar growth rate in Nude, SCID, SCID Beige and Rag2<sup>&#8722;/&#8722;</sup> &#947;c<sup>&#8722;/&#8722;</sup> mice. <bold>a</bold> Tumor growth rate monitored in the Nude (<italic>n</italic>&#160;=&#160;5), SCID (<italic>n</italic>&#160;=&#160;5), SCID Beige (<italic>n</italic>&#160;=&#160;5) and Rag2<sup>&#8722;/&#8722;</sup> &#947;c<sup>&#8722;/&#8722;</sup> (<italic>n</italic>&#160;=&#160;6) mice by measuring the volume over the time period of the experiment. <bold>b</bold> Primary tumor weight at the end point of the spontaneous metastasis assay (<italic>P</italic>&#160;&gt;&#160;0.05)</p>
###xml 2824 3196 2808 3172 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="47">MTLn3-GFP-ErbB1 cells have a similar growth rate in Nude, SCID, SCID Beige and Rag2<sup>&#8722;/&#8722;</sup> &#947;c<sup>&#8722;/&#8722;</sup> mice. <bold>a</bold> Tumor growth rate monitored in the Nude (<italic>n</italic>&#160;=&#160;5), SCID (<italic>n</italic>&#160;=&#160;5), SCID Beige (<italic>n</italic>&#160;=&#160;5) and Rag2<sup>&#8722;/&#8722;</sup> &#947;c<sup>&#8722;/&#8722;</sup> (<italic>n</italic>&#160;=&#160;6) mice by measuring the volume over the time period of the experiment. <bold>b</bold> Primary tumor weight at the end point of the spontaneous metastasis assay (<italic>P</italic>&#160;&gt;&#160;0.05)</p></caption>
###xml 3196 3196 3172 3172 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="10585_2009_9267_Fig4_HTML" id="MO4"/>
###xml 2818 3196 2802 3172 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig4"><label>Fig.&#160;4</label><caption><p textid="47">MTLn3-GFP-ErbB1 cells have a similar growth rate in Nude, SCID, SCID Beige and Rag2<sup>&#8722;/&#8722;</sup> &#947;c<sup>&#8722;/&#8722;</sup> mice. <bold>a</bold> Tumor growth rate monitored in the Nude (<italic>n</italic>&#160;=&#160;5), SCID (<italic>n</italic>&#160;=&#160;5), SCID Beige (<italic>n</italic>&#160;=&#160;5) and Rag2<sup>&#8722;/&#8722;</sup> &#947;c<sup>&#8722;/&#8722;</sup> (<italic>n</italic>&#160;=&#160;6) mice by measuring the volume over the time period of the experiment. <bold>b</bold> Primary tumor weight at the end point of the spontaneous metastasis assay (<italic>P</italic>&#160;&gt;&#160;0.05)</p></caption><graphic position="anchor" xlink:href="10585_2009_9267_Fig4_HTML" id="MO4"/></fig>
###xml 107 111 <span type="species:ncbi:10116">rats</span>
###xml 155 160 <span type="species:ncbi:10090">mouse</span>
###xml 512 517 <span type="species:ncbi:10090">mouse</span>
###xml 602 611 <span type="species:ncbi:10090">nude mice</span>
###xml 694 698 <span type="species:ncbi:10090">mice</span>
###xml 748 752 <span type="species:ncbi:10090">mice</span>
###xml 814 818 <span type="species:ncbi:10090">mice</span>
###xml 906 911 <span type="species:ncbi:10090">mouse</span>
###xml 1196 1200 <span type="species:ncbi:10090">mice</span>
###xml 1255 1259 <span type="species:ncbi:10090">mice</span>
###xml 1277 1281 <span type="species:ncbi:10090">mice</span>
###xml 1438 1442 <span type="species:ncbi:10090">mice</span>
###xml 1538 1542 <span type="species:ncbi:10090">mice</span>
###xml 1577 1582 <span type="species:ncbi:10090">mouse</span>
###xml 1695 1700 <span type="species:ncbi:10090">mouse</span>
###xml 1804 1809 <span type="species:ncbi:10090">mouse</span>
###xml 2030 2035 <span type="species:ncbi:10090">mouse</span>
###xml 2214 2218 <span type="species:ncbi:10090">mice</span>
###xml 2478 2482 <span type="species:ncbi:10090">mice</span>
###xml 2921 2925 <span type="species:ncbi:10090">mice</span>
###xml 3041 3045 <span type="species:ncbi:10090">mice</span>
Previously, we demonstrated a negative role of NK immune cells in lung metastasis formation in Fischer 344 rats [27]. We analyzed several immune deficient mouse models for their capacity to support orthotopic breast cancer metastasis formation. Since ErbB1 enhances intravasation of MTLn3 tumor cells and GFP enables FLI and easy counting of individual lung metastases [14, 30, 31], we used the MTLn3-GFP-ErbB1 cell line to screen for the most suitable orthotopic breast/tumor metastasis model. We selected four mouse strains with different immunodeficiency backgrounds (see Table 1). The conventional nude mice still possess B lymphocytes and NK cells. Severe combined immunodeficiency (SCID) mice lack T and B cells but have NK cells. SCID Beige mice also lack NK cells [6, 18, 20-23, 25, 32]. Rag2-/- gammac-/- mice lack both the adaptive and innate immune response. The common gamma (gammac) knock-out mouse lacks functional receptors for many cytokines including IL-2, IL-4, IL-7, IL-9 and IL-15. As a consequence, lymphocyte development is greatly compromised and NK cells are not present. Elimination of the residual T and B cells in the gammac-/- background is obtained by crossing these mice to the recombinase activating gene 2 (Rag2) deficient mice [6, 32]. All the mice were injected with 500,000 MTLn3-GFP-ErbB1 cells in the right thoracic mammary fat pad. We followed the primary tumor growth for 4 weeks and sacrificed the mice when the tumors reached an average size of 10 mm x 10 mm. The primary tumor growth rate in all mice strains except for the SCID Beige mouse was similar. The xenografts in the SCID Beige appeared to show delayed growth but the difference with the other mouse strains was not significant. Furthermore, the average tumor weight was comparable with the other three mouse strains (Fig. 4a, b). Overall the primary tumor volume varied between 300 and 500 mm3 (Fig. 4a) and tumor weight between 300 and 500 mg (Fig. 4b). Both volume and weight were not significantly different between the four mouse strains. No difference was noticed in tumor organization, as determined by H&E staining (data not shown). No necrotic regions were observed in any of the tumors of the different mice strains. Since there was no significant difference in tumor weight especially between the SCID and the SCID Beige, the results suggest that NK cells do not interfere with the tumor growth of the MTLn3-GFP-ErbB1 cells.Table 1Characteristics of immunodeficient mice usedStrainAdaptive immunityInnate immunityReferenceBALB/c nu/nu 6 [Nude]T cell deficiency[52]CB17/lcr-PrkdcSCID/Crl [SCID]T and B cell deficiency[53-55]CB17/lcr.Cg-PrkdcSCID Lystbg/Crl [SCID Beige]T and B cell deficiencyReduced NK cell function[35, 36, 56]Rag2-/- gammac-/- [Rag]T and B cell deficiencyNK cell deficiency[6, 32, 57, 58]Fig. 4MTLn3-GFP-ErbB1 cells have a similar growth rate in Nude, SCID, SCID Beige and Rag2-/- gammac-/- mice. a Tumor growth rate monitored in the Nude (n = 5), SCID (n = 5), SCID Beige (n = 5) and Rag2-/- gammac-/- (n = 6) mice by measuring the volume over the time period of the experiment. b Primary tumor weight at the end point of the spontaneous metastasis assay (P > 0.05)
###end p 45
###begin p 46
###xml 35 39 <span type="species:ncbi:10090">mice</span>
Characteristics of immunodeficient mice used
###end p 46
###begin p 47
###xml 83 86 83 86 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 93 96 89 92 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 103 104 99 100 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 146 147 142 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 160 161 156 157 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 180 181 176 177 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 195 198 191 194 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 205 208 197 200 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 210 211 202 203 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 286 287 278 279 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 363 364 355 356 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 97 101 <span type="species:ncbi:10090">mice</span>
###xml 217 221 <span type="species:ncbi:10090">mice</span>
MTLn3-GFP-ErbB1 cells have a similar growth rate in Nude, SCID, SCID Beige and Rag2-/- gammac-/- mice. a Tumor growth rate monitored in the Nude (n = 5), SCID (n = 5), SCID Beige (n = 5) and Rag2-/- gammac-/- (n = 6) mice by measuring the volume over the time period of the experiment. b Primary tumor weight at the end point of the spontaneous metastasis assay (P > 0.05)
###end p 47
###begin title 48
###xml 58 61 58 61 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 68 71 64 67 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 87 91 <span type="species:ncbi:10090">mice</span>
Efficient orthotopic lung metastasis formation in the Rag2-/- gammac-/- and SCID Beige mice
###end title 48
###begin p 49
###xml 386 387 386 387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig5" ref-type="fig">5</xref>
###xml 499 500 499 500 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig4" ref-type="fig">4</xref>
###xml 570 571 570 571 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig5" ref-type="fig">5</xref>
###xml 622 625 622 625 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 632 635 628 631 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 728 731 724 727 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 738 741 730 733 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 753 754 745 746 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig5" ref-type="fig">5</xref>
###xml 933 934 925 926 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 952 955 944 947 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 962 965 950 953 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 997 998 985 986 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 1005 1006 993 994 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig5" ref-type="fig">5</xref>
###xml 1202 1205 1190 1193 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1212 1215 1196 1199 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1227 1228 1211 1212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig5" ref-type="fig">5</xref>
###xml 1334 1337 1318 1321 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1344 1347 1324 1327 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1709 1711 1689 1691 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR33">33</xref>
###xml 1713 1715 1693 1695 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR34">34</xref>
###xml 1869 1872 1849 1852 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1879 1882 1855 1858 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1889 1891 1865 1867 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR35">35</xref>
###xml 1893 1895 1869 1871 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR36">36</xref>
###xml 1897 1903 1873 1879 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;5</label>
###xml 2101 2102 2077 2078 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 2183 2184 2159 2160 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 2191 2192 2167 2168 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 2202 2203 2178 2179 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 2287 2290 2263 2266 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bar</italic>
###xml 2311 2312 2286 2287 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 2368 2379 2343 2354 <italic xmlns:xlink="http://www.w3.org/1999/xlink">right lobes</italic>
###xml 2391 2400 2366 2375 <italic xmlns:xlink="http://www.w3.org/1999/xlink">left lobe</italic>
###xml 1903 2432 1879 2407 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="50">NK cells interfere with lung metastasis formation. After sacrifice, the number of GFP-positive lung metastases was counted ex vivo using an inverted fluorescent microscope and a &#215;10 objective lens. <bold>a</bold> Number of lung metastases at the end point of the spontaneous metastasis assay (<italic>t</italic>-test, <italic>P</italic>&#160;&lt;&#160;0.05). <bold>b</bold> Images of the four different sizes of lung metastases encountered during counting. <italic>Bar</italic> represents 100&#160;&#956;m. <bold>c</bold> After 5&#160;weeks, lungs were isolated, injected with ink (<italic>right lobes</italic>) and lung (<italic>left lobe</italic>) sections were stained with H&amp;E</p>
###xml 1903 2432 1879 2407 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="50">NK cells interfere with lung metastasis formation. After sacrifice, the number of GFP-positive lung metastases was counted ex vivo using an inverted fluorescent microscope and a &#215;10 objective lens. <bold>a</bold> Number of lung metastases at the end point of the spontaneous metastasis assay (<italic>t</italic>-test, <italic>P</italic>&#160;&lt;&#160;0.05). <bold>b</bold> Images of the four different sizes of lung metastases encountered during counting. <italic>Bar</italic> represents 100&#160;&#956;m. <bold>c</bold> After 5&#160;weeks, lungs were isolated, injected with ink (<italic>right lobes</italic>) and lung (<italic>left lobe</italic>) sections were stained with H&amp;E</p></caption>
###xml 2432 2432 2407 2407 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="10585_2009_9267_Fig5_HTML" id="MO5"/>
###xml 1897 2432 1873 2407 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig5"><label>Fig.&#160;5</label><caption><p textid="50">NK cells interfere with lung metastasis formation. After sacrifice, the number of GFP-positive lung metastases was counted ex vivo using an inverted fluorescent microscope and a &#215;10 objective lens. <bold>a</bold> Number of lung metastases at the end point of the spontaneous metastasis assay (<italic>t</italic>-test, <italic>P</italic>&#160;&lt;&#160;0.05). <bold>b</bold> Images of the four different sizes of lung metastases encountered during counting. <italic>Bar</italic> represents 100&#160;&#956;m. <bold>c</bold> After 5&#160;weeks, lungs were isolated, injected with ink (<italic>right lobes</italic>) and lung (<italic>left lobe</italic>) sections were stained with H&amp;E</p></caption><graphic position="anchor" xlink:href="10585_2009_9267_Fig5_HTML" id="MO5"/></fig>
###xml 93 98 <span type="species:ncbi:10090">mouse</span>
###xml 137 141 <span type="species:ncbi:10090">mice</span>
###xml 215 219 <span type="species:ncbi:10090">mice</span>
###xml 479 484 <span type="species:ncbi:10090">mouse</span>
###xml 559 563 <span type="species:ncbi:10090">mice</span>
###xml 651 655 <span type="species:ncbi:10090">mice</span>
###xml 742 746 <span type="species:ncbi:10090">mice</span>
###xml 866 870 <span type="species:ncbi:10090">mice</span>
###xml 966 970 <span type="species:ncbi:10090">mice</span>
###xml 1216 1220 <span type="species:ncbi:10090">mice</span>
###xml 1287 1291 <span type="species:ncbi:10090">mice</span>
###xml 1348 1352 <span type="species:ncbi:10090">mice</span>
###xml 1842 1846 <span type="species:ncbi:10090">mice</span>
###xml 1883 1887 <span type="species:ncbi:10090">mice</span>
After orthotopic transplantation of MTLn3 cells into the mammary gland of the four different mouse strains, primary tumors formed in all mice. Next we checked for the number of lung metastases after sacrificing the mice. The presence of GFP in the MTLn3 cells allowed the quantification of the lung metastases and classification according to their size by fluorescence microscopy (Fig. 5b). While there was no significant difference in primary tumor growth in the four different mouse strains (Fig. 4), almost no lung metastases were observed in nude or SCID mice (Fig. 5a). Many lung metastases were observed in both Rag2-/- gammac-/- and SCID Beige mice, although the latter showed significantly fewer metastases than the Rag2-/- gammac-/- mice (Fig. 5a). Visualization of individual metastases by immunofluorescence microscopy demonstrated that in the SCID Beige mice the size of the metastases ranged from less than 0.1 to 0.3 mm2 while in the Rag2-/- gammac-/- mice they were all above 0.3 mm2 (Fig. 5b). When the lungs were injected with ink, it was not possible to observe metastases in the SCID Beige; they were only visible with HE staining. However metastases were clearly visible in the Rag2-/- gammac-/- mice (Fig. 5c). Since NK cells are still present in both nude and SCID mice but are absent in both SCID Beige and Rag2-/- gammac-/- mice, it shows that the presence of NK cells is the limiting factor for efficient lung metastasis formation in orthotopic breast cancer models. The beige mutation not only results in loss of cytotoxic T cells and selective impairment of NK cell functions but also in macrophage defects. Macrophages have been shown to influence MTLn3 lung metastasis formation [33, 34]. This could explain the lower average tumor weight and most probably the reduced number of lung metastases in the SCID Beige mice compared with the Rag2-/- gammac-/- mice [35, 36].Fig. 5NK cells interfere with lung metastasis formation. After sacrifice, the number of GFP-positive lung metastases was counted ex vivo using an inverted fluorescent microscope and a x10 objective lens. a Number of lung metastases at the end point of the spontaneous metastasis assay (t-test, P < 0.05). b Images of the four different sizes of lung metastases encountered during counting. Bar represents 100 mum. c After 5 weeks, lungs were isolated, injected with ink (right lobes) and lung (left lobe) sections were stained with H&E
###end p 49
###begin p 50
###xml 198 199 198 199 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 280 281 280 281 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 288 289 288 289 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 299 300 299 300 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 384 387 384 387 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bar</italic>
###xml 408 409 407 408 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 465 476 464 475 <italic xmlns:xlink="http://www.w3.org/1999/xlink">right lobes</italic>
###xml 488 497 487 496 <italic xmlns:xlink="http://www.w3.org/1999/xlink">left lobe</italic>
NK cells interfere with lung metastasis formation. After sacrifice, the number of GFP-positive lung metastases was counted ex vivo using an inverted fluorescent microscope and a x10 objective lens. a Number of lung metastases at the end point of the spontaneous metastasis assay (t-test, P < 0.05). b Images of the four different sizes of lung metastases encountered during counting. Bar represents 100 mum. c After 5 weeks, lungs were isolated, injected with ink (right lobes) and lung (left lobe) sections were stained with H&E
###end p 50
###begin title 51
###xml 58 61 58 61 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 68 71 64 67 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
Efficient orthotopic lung metastasis formation in the Rag2-/- gammac-/- using the 4T1-luc cell-line
###end title 51
###begin p 52
###xml 82 85 82 85 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 92 95 88 91 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 180 183 176 179 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 190 193 182 185 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 414 416 406 408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR37">37</xref>
###xml 491 494 483 486 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 501 504 489 492 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 617 620 605 608 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 627 630 611 614 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 642 643 626 627 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig6" ref-type="fig">6</xref>
###xml 812 813 796 797 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig6" ref-type="fig">6</xref>
###xml 893 896 877 880 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 903 906 883 886 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 942 943 922 923 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig6" ref-type="fig">6</xref>
###xml 1056 1059 1036 1039 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1066 1069 1042 1045 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1114 1117 1090 1093 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1124 1127 1096 1099 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1180 1186 1152 1158 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;6</label>
###xml 1240 1243 1212 1215 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1250 1253 1218 1221 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1307 1308 1275 1276 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 1365 1368 1333 1336 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1375 1378 1339 1342 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1385 1386 1349 1350 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1416 1417 1380 1381 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1437 1438 1401 1402 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 1514 1515 1478 1479 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1525 1526 1489 1490 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 1562 1572 1526 1536 <italic xmlns:xlink="http://www.w3.org/1999/xlink">right lobe</italic>
###xml 1634 1635 1598 1599 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d</bold>
###xml 1706 1707 1670 1671 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 1714 1715 1678 1679 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1186 1725 1158 1689 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="53">4T1-luc cells metastasize more efficiently in the Rag2<sup>&#8722;/&#8722;</sup> &#947;c<sup>&#8722;/&#8722;</sup> mice than in their syngeneic mouse model the Balb/c. <bold>a</bold> Tumor growth rate of the 4T1 cells monitored in the Rag2<sup>&#8722;/&#8722;</sup> &#947;c<sup>&#8722;/&#8722;</sup> mice (<italic>n</italic>&#160;=&#160;5) and in the Balb/C mice (<italic>n</italic>&#160;=&#160;5) over 3&#160;weeks. <bold>b</bold> Primary tumor weight at the end point of the spontaneous metastasis assay (<italic>P</italic>&#160;&gt;&#160;0.05). <bold>c</bold> Example of lung injected with ink (<italic>right lobe</italic>) to show number and size of metastases in both mouse models. <bold>d</bold> Lung metastases at the end point of the spontaneous metastasis assay (<italic>t</italic>-test, <italic>P</italic>&#160;=&#160;0.0040)</p>
###xml 1186 1725 1158 1689 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="53">4T1-luc cells metastasize more efficiently in the Rag2<sup>&#8722;/&#8722;</sup> &#947;c<sup>&#8722;/&#8722;</sup> mice than in their syngeneic mouse model the Balb/c. <bold>a</bold> Tumor growth rate of the 4T1 cells monitored in the Rag2<sup>&#8722;/&#8722;</sup> &#947;c<sup>&#8722;/&#8722;</sup> mice (<italic>n</italic>&#160;=&#160;5) and in the Balb/C mice (<italic>n</italic>&#160;=&#160;5) over 3&#160;weeks. <bold>b</bold> Primary tumor weight at the end point of the spontaneous metastasis assay (<italic>P</italic>&#160;&gt;&#160;0.05). <bold>c</bold> Example of lung injected with ink (<italic>right lobe</italic>) to show number and size of metastases in both mouse models. <bold>d</bold> Lung metastases at the end point of the spontaneous metastasis assay (<italic>t</italic>-test, <italic>P</italic>&#160;=&#160;0.0040)</p></caption>
###xml 1725 1725 1689 1689 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="10585_2009_9267_Fig6_HTML" id="MO6"/>
###xml 1180 1725 1152 1689 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig6"><label>Fig.&#160;6</label><caption><p textid="53">4T1-luc cells metastasize more efficiently in the Rag2<sup>&#8722;/&#8722;</sup> &#947;c<sup>&#8722;/&#8722;</sup> mice than in their syngeneic mouse model the Balb/c. <bold>a</bold> Tumor growth rate of the 4T1 cells monitored in the Rag2<sup>&#8722;/&#8722;</sup> &#947;c<sup>&#8722;/&#8722;</sup> mice (<italic>n</italic>&#160;=&#160;5) and in the Balb/C mice (<italic>n</italic>&#160;=&#160;5) over 3&#160;weeks. <bold>b</bold> Primary tumor weight at the end point of the spontaneous metastasis assay (<italic>P</italic>&#160;&gt;&#160;0.05). <bold>c</bold> Example of lung injected with ink (<italic>right lobe</italic>) to show number and size of metastases in both mouse models. <bold>d</bold> Lung metastases at the end point of the spontaneous metastasis assay (<italic>t</italic>-test, <italic>P</italic>&#160;=&#160;0.0040)</p></caption><graphic position="anchor" xlink:href="10585_2009_9267_Fig6_HTML" id="MO6"/></fig>
###xml 96 100 <span type="species:ncbi:10090">mice</span>
###xml 194 199 <span type="species:ncbi:10090">mouse</span>
###xml 384 389 <span type="species:ncbi:10090">mouse</span>
###xml 407 412 <span type="species:ncbi:10090">mouse</span>
###xml 516 520 <span type="species:ncbi:10090">mice</span>
###xml 631 635 <span type="species:ncbi:10090">mice</span>
###xml 718 723 <span type="species:ncbi:10090">mouse</span>
###xml 792 797 <span type="species:ncbi:10090">mouse</span>
###xml 907 911 <span type="species:ncbi:10090">mice</span>
###xml 931 935 <span type="species:ncbi:10090">mice</span>
###xml 1070 1075 <span type="species:ncbi:10090">mouse</span>
###xml 1128 1132 <span type="species:ncbi:10090">mice</span>
###xml 1168 1173 <span type="species:ncbi:10090">mouse</span>
###xml 1254 1258 <span type="species:ncbi:10090">mice</span>
###xml 1283 1288 <span type="species:ncbi:10090">mouse</span>
###xml 1379 1383 <span type="species:ncbi:10090">mice</span>
###xml 1410 1414 <span type="species:ncbi:10090">mice</span>
###xml 1620 1625 <span type="species:ncbi:10090">mouse</span>
Orthotopic transplantation of MTLn3-GFP-ErbB1 cells into the mammary gland of Rag2-/- gammac-/- mice resulted in a high number of lung metastases. We also examined whether the Rag2-/- gammac-/- mouse is a good recipient for another highly metastatic cell-line, 4T1-luc. This cell-line is supposed to metastasize easily to the lungs and other target organs in the syngeneic orthotopic mouse model the Balb/c mouse [37]. We injected 100,000 4T1-luc cells in the T4 mammary fat pad of both Rag2-/- gammac-/- and Balb/c mice. Over a time period of 3 weeks, we observed a significantly higher tumor growth rate in the Rag2-/- gammac-/- mice (Fig. 6a), which we attribute to the influence of the immune system of the Balb/c mouse. At time of sacrifice, the primary tumor weight was similar in both mouse strains (Fig. 6b), however there were significantly more and larger lung metastases in the Rag2-/- gammac-/- mice than in the Balb/c mice (Fig. 6c, d). After 3 weeks, only a high number of lung metastases formed by 4T1-luc cells could be observed in the Rag2-/- gammac-/- mouse model. We therefore conclude that Rag2-/- gammac-/- mice represent a suitable breast cancer mouse model.Fig. 64T1-luc cells metastasize more efficiently in the Rag2-/- gammac-/- mice than in their syngeneic mouse model the Balb/c. a Tumor growth rate of the 4T1 cells monitored in the Rag2-/- gammac-/- mice (n = 5) and in the Balb/C mice (n = 5) over 3 weeks. b Primary tumor weight at the end point of the spontaneous metastasis assay (P > 0.05). c Example of lung injected with ink (right lobe) to show number and size of metastases in both mouse models. d Lung metastases at the end point of the spontaneous metastasis assay (t-test, P = 0.0040)
###end p 52
###begin p 53
###xml 54 57 54 57 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 64 67 60 63 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 121 122 117 118 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 179 182 175 178 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 189 192 181 184 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 199 200 191 192 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 230 231 222 223 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 251 252 243 244 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 328 329 320 321 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 339 340 331 332 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 376 386 368 378 <italic xmlns:xlink="http://www.w3.org/1999/xlink">right lobe</italic>
###xml 448 449 440 441 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d</bold>
###xml 520 521 512 513 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 528 529 520 521 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 68 72 <span type="species:ncbi:10090">mice</span>
###xml 97 102 <span type="species:ncbi:10090">mouse</span>
###xml 193 197 <span type="species:ncbi:10090">mice</span>
###xml 224 228 <span type="species:ncbi:10090">mice</span>
###xml 434 439 <span type="species:ncbi:10090">mouse</span>
4T1-luc cells metastasize more efficiently in the Rag2-/- gammac-/- mice than in their syngeneic mouse model the Balb/c. a Tumor growth rate of the 4T1 cells monitored in the Rag2-/- gammac-/- mice (n = 5) and in the Balb/C mice (n = 5) over 3 weeks. b Primary tumor weight at the end point of the spontaneous metastasis assay (P > 0.05). c Example of lung injected with ink (right lobe) to show number and size of metastases in both mouse models. d Lung metastases at the end point of the spontaneous metastasis assay (t-test, P = 0.0040)
###end p 53
###begin title 54
Discussion
###end title 54
###begin p 55
###xml 218 219 218 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR7">7</xref>
###xml 421 424 421 424 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 431 434 427 430 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 475 477 471 473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR12">12</xref>
###xml 479 481 475 477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR13">13</xref>
###xml 483 485 479 481 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR16">16</xref>
###xml 435 439 <span type="species:ncbi:10090">mice</span>
Modeling metastasis in vivo is challenging but necessary for studying the mechanisms underlying the tumor cell biological processes (e.g. cell migration) that enable certain cells to spread to other parts of the body [7]. EGFR-signaling is a pathway that is known to be involved in breast tumor progression. We examined whether EGFR overexpression in MTLn3 cells results in increased number of lung metastases in the Rag2-/- gammac-/- mice. In contrast of previous findings [12, 13, 16], our data indicate that increased expression of ErbB1 in the MTLn3 mammary adenocarcinoma cells results in slower primary tumor growth. In vitro, MTLn3-GFP-ErbB1 cells show an increased proliferation rate compared with control cells, suggesting instead that there may be a difference in cell survival. Indeed, MTLn3-GFP-ErbB1 cells are less able to tolerate culture at high density compared to MTLn3-GFP control cells. MTLn3-GFP-ErbB1 cells may be less tolerant of the fat pad injection procedure resulting in fewer surviving cells that can develop into a primary tumor.
###end p 55
###begin p 56
###xml 150 153 150 153 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 160 163 156 159 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 686 688 682 684 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR33">33</xref>
###xml 690 692 686 688 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR34">34</xref>
###xml 877 880 873 876 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 887 890 879 882 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 164 168 <span type="species:ncbi:10090">mice</span>
###xml 246 250 <span type="species:ncbi:10090">mice</span>
###xml 365 369 <span type="species:ncbi:10090">mice</span>
###xml 891 895 <span type="species:ncbi:10090">mice</span>
ErbB1 overexpression enhances the ability to intravasate and, thus, provide sufficient seeding capacity to allow lung metastasis formation in the Rag2-/- gammac-/- mice. Indeed, there were an increased number of tumor cells in the circulation of mice with ErbB1-expressing tumors, while few cells could be detected in the blood collected from control tumor bearing mice. Furthermore, the efficiency of lung colonization by MTLn3 cells (experimental metastasis assay) was independent of ErbB1 overexpression. These results are consistent with previous in vivo studies showing that ErbB1 expression can enhance invasiveness-most probably through increased chemotaxis to gradients of EGF [33, 34]. The angiogenesis marker, CD31, failed to reveal differences in blood vessel density through the primary tumor of both groups (data not shown). The presence of macrophages in the Rag2-/- gammac-/- mice allows the paracrine loop with tumor cells to take place and thus enhances invasiveness in response to EGF.
###end p 56
###begin p 57
###xml 223 224 223 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR6">6</xref>
###xml 226 228 226 228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR17">17</xref>
###xml 230 232 230 232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR27">27</xref>
###xml 234 236 234 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR38">38</xref>
###xml 274 277 274 277 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 284 287 280 283 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 551 553 547 549 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR27">27</xref>
###xml 555 557 551 553 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR39">39</xref>
###xml 558 560 554 556 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR42">42</xref>
###xml 592 594 588 590 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR43">43</xref>
###xml 689 693 681 685 <sup xmlns:xlink="http://www.w3.org/1999/xlink">null</sup>
###xml 760 763 752 755 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 770 773 758 761 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1076 1078 1064 1066 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR44">44</xref>
###xml 1369 1372 1357 1360 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1379 1382 1363 1366 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1500 1503 1484 1487 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1510 1513 1490 1493 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1555 1557 1535 1537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR45">45</xref>
###xml 1582 1585 1562 1565 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1592 1595 1568 1571 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1628 1632 1600 1604 <sup xmlns:xlink="http://www.w3.org/1999/xlink">null</sup>
###xml 2210 2212 2182 2184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR35">35</xref>
###xml 2214 2216 2186 2188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR36">36</xref>
###xml 2361 2363 2333 2335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR33">33</xref>
###xml 2365 2367 2337 2339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR34">34</xref>
###xml 2369 2371 2341 2343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR46">46</xref>
###xml 2373 2375 2345 2347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR47">47</xref>
###xml 122 127 <span type="species:ncbi:10090">mouse</span>
###xml 288 293 <span type="species:ncbi:10090">mouse</span>
###xml 700 704 <span type="species:ncbi:10090">mice</span>
###xml 774 778 <span type="species:ncbi:10090">mice</span>
###xml 917 922 <span type="species:ncbi:9606">human</span>
###xml 969 973 <span type="species:ncbi:10090">mice</span>
###xml 995 999 <span type="species:ncbi:10090">mice</span>
###xml 1107 1110 <span type="species:ncbi:10116">rat</span>
###xml 1391 1395 <span type="species:ncbi:10090">mice</span>
###xml 1514 1519 <span type="species:ncbi:10090">mouse</span>
###xml 1596 1600 <span type="species:ncbi:10090">mice</span>
###xml 1639 1643 <span type="species:ncbi:10090">mice</span>
###xml 1692 1697 <span type="species:ncbi:9606">human</span>
###xml 1890 1894 <span type="species:ncbi:10090">mice</span>
###xml 2420 2424 <span type="species:ncbi:10090">mice</span>
###xml 2529 2533 <span type="species:ncbi:10090">mice</span>
In this study, we have shown that the presence of remaining innate immune cells, including NK cells, in the nude and SCID mouse does not affect the growth of the primary tumor but inhibits the formation of lung metastases [6, 17, 27, 38]. Indeed, we have found that the Rag2-/- gammac-/- mouse which lacks NK cells is an excellent recipient animal model to study breast tumor formation and progression when using MTLn3 overexpressing ErbB1 cells or 4T1 cells. Previous reports demonstrated the contribution of NK cells in tumor growth and metastasis [27, 39-42]. In particular, Dewan et al. [43] demonstrated the direct role of NK cells in tumor growth and metastasis using NOD/SCID/gammacnull (NOG) mice lacking T, B and NK cells which are similar to the Rag2-/- gammac-/- mice used in our study. They showed both increased efficiency of engraftment (subcutaneous inoculation only) and spontaneous metastasis of the human breast cancer cell-line MB-MDA-231 in the NOG mice compared to the SCID mice demonstrating the critical role of NK cells in tumor growth and metastasis [44]. In our study, we used the rat mammary adenocarcinoma MTLn3 cell-line overexpressing ErbB1. Although we did not observe a significant role for NK cells in engraftment and primary tumor growth, they did appear to be important for the formation of spontaneous lung metastases. Since the Rag2-/- gammac-/- and NOG mice have similar immunodeficiencies, i.e. T, B, and NK cell reductions, similar results for the NOG and Rag2-/- gammac-/- mouse were to be expected. Zhang et al. [45] also conclude that Rag2-/- gammac-/- mice, similar to NOD/SCID/gammacnull (NOG) mice, provide a suitable immunodeficient setting for human engraftment. Nevertheless, our results concerning efficient engraftment of the tumor cells do not show that NK cells play a role in this tumor progression step. Tumor growth in the SCID Beige mice was slightly delayed although these also lack NK cells. In fact, the beige mutation not only results in loss of cytotoxic T cells and selective impairment of NK cell functions but also in macrophage defects which could explain the lower average tumor weight and most probably the reduced number of lung metastases [35, 36]. Indeed, it has been shown that macrophages can form a paracrine loop with tumor cells to enhance invasiveness in response to EGF stimulation [33, 34, 46, 47]. Reduced macrophage activity in SCID Beige mice could therefore explain why tumor growth and the number of lung metastases were reduced compared to Rag mice.
###end p 57
###begin p 58
###xml 161 163 161 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR48">48</xref>
###xml 216 218 216 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR49">49</xref>
###xml 555 556 555 556 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 711 713 711 713 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR50">50</xref>
###xml 829 832 829 832 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 839 842 835 838 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1322 1324 1318 1320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR51">51</xref>
###xml 1529 1531 1525 1527 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR12">12</xref>
###xml 1533 1535 1529 1531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR13">13</xref>
###xml 1593 1596 1589 1592 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1603 1606 1595 1598 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1672 1675 1664 1667 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1682 1685 1670 1673 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1915 1917 1903 1905 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR37">37</xref>
###xml 32 37 <span type="species:ncbi:10090">mouse</span>
###xml 121 126 <span type="species:ncbi:9606">human</span>
###xml 312 316 <span type="species:ncbi:10090">mice</span>
###xml 571 575 <span type="species:ncbi:10090">mice</span>
###xml 622 626 <span type="species:ncbi:10090">mice</span>
###xml 843 847 <span type="species:ncbi:10090">mice</span>
###xml 1142 1147 <span type="species:ncbi:10090">mouse</span>
###xml 1301 1306 <span type="species:ncbi:9606">human</span>
###xml 1382 1387 <span type="species:ncbi:10090">mouse</span>
###xml 1618 1622 <span type="species:ncbi:10090">mice</span>
###xml 1686 1690 <span type="species:ncbi:10090">mice</span>
###xml 1731 1736 <span type="species:ncbi:10090">mouse</span>
###xml 1829 1833 <span type="species:ncbi:10090">mice</span>
###xml 1999 2003 <span type="species:ncbi:10090">mice</span>
###xml 2138 2142 <span type="species:ncbi:10090">mice</span>
###xml 2251 2255 <span type="species:ncbi:10090">mice</span>
To further confirm that the Rag mouse is a suitable animal model for studying breast cancer progression, we injected two human xenografts models MDA-MB-231-luc [48] and a bone metastastic variant BO2-MDA-MB-231-luc [49] cell-lines. These MDA-MB-231 cell lines poorly grew after orthotopic transplantation in Rag mice (data not shown). Typically, these cell lines are used in intracardial injection studies for bone metastasis model. The parental MB-MDA-231 cells do grow orthopically to 1 cm in diameter typically in 30-35 days after inoculation of 1 x 106 cells in SCID mice. After removal of the mammary fat pad tumors, mice are then sacrificed 4-5 weeks later and few spontaneous metastases can be detected [50]. Although not tested, we anticipate that the parental MB-MDA-231 cells would form orthotopic breast tumors in Rag2-/- gammac-/- mice, but the necessary removal of the primary tumor for further metastases development as well as the ultimate number of lung metastasis formed, does not fit our requirements for an easy and reliable breast cancer/metastasis animal model. In addition to our MTLn3 cell line, we also tested the 4T1 mouse mammary tumor cell-line, which is known to be one of the only few breast cancer models with the capacity to metastasize efficiently to sites affected in human breast cancer [51]. When introduced orthotopically in the syngeneic Balb/c mouse model which possesses an intact immune system, 4T1 should be capable of metastasising to several organs typically affected in breast cancer [12, 13]. However, when we injected the 4T1-luc cells in the Rag2-/- gammac-/- and Balb/c mice, we could only detect lung metastases in the Rag2-/- gammac-/- mice although a primary tumor formed in both mouse strains. Even after 3 weeks of experiment the primary tumor started to shrink in the Balb/c mice which has been described as a biphasic growth related to immune system function [37]. Indeed, Tao et al. observed a regression in weeks 2 through 4 in normal BALB/c mice which was associated with necrosis and infiltration of leukocytes. Biphasic tumor growth did not occur in athymic nude or SCID BALB/c mice suggesting involvement of an acquired immune response in the effect. We also injected the 4T1-luc in Balb/c mice purchased from different suppliers (data not shown). The results were similar: very few lung metastases detectable. In conclusion, our results suggest that NK cells play an important role in inhibiting metastasis formation but not in tumor growth.
###end p 58
###begin p 59
###xml 503 511 <span type="species:ncbi:9606">patients</span>
In summary, ErbB1 overexpression in the MTln3 cells delayed the primary tumor growth but was essential for efficient intravasation and lung metastasis formation. This suggests a role for ErbB1 expression in tumor cells to drive the biological processes that are essential in intravasation, such as cell motility. Secondly, we provide evidence for the crucial role of NK cells in metastasis formation but not in tumor growth. Metastasis formation is a key determinant of poor prognosis for breast cancer patients; enhancing NK activity is therefore a potential immunotherapeutic strategy for combatting this detrimental step.
###end p 59
###begin p 60
###xml 8 11 8 11 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 18 21 14 17 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 22 27 <span type="species:ncbi:10090">mouse</span>
The Rag2-/- gammac-/- mouse model, in combination with MTLn3-ErbB1 and 4T1 tumor cells, is a clinically relevant model for the study of breast cancer cell growth and metastasis. The 4T1 syngeneic metastatic breast cancer model may be useful to validate potential gene targets and processes implicated in cell migration and intravasation.
###end p 60
###begin title 61
Electronic supplementary material
###end title 61
###begin p 62
Below is the link to the electronic supplementary material. 
###end p 62
###begin p 63
###xml 93 96 93 96 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 103 106 99 102 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 114 115 110 111 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 236 237 232 233 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 264 265 260 261 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 273 274 269 270 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 418 419 414 415 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 430 431 426 427 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 582 583 578 579 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 107 111 <span type="species:ncbi:10090">mice</span>
###xml 199 203 <span type="species:ncbi:10090">mice</span>
###xml 355 359 <span type="species:ncbi:10090">mice</span>
 ErbB1 over-expression delays tumor growth but enhances lung metastasis formation in the Rag2-/- gammac-/- mice. (a) Primary tumor growth measured by caliper during spontaneous metastasis assay. Rag mice were inoculated with MTLn3-GFP (n = 4) and MTLn3-GFP-ErbB1 (n = 4). (b) Primary tumor weight at the end point of the spontaneous metastasis assay. The mice were sacrificed exactly 25 days after fat pad injection. (p < 0.05). (c) Number of lung metastases counted with a fluorescent microscope at x10 magnification at the end point (day 25) of the spontaneous metastasis assays (p > 0.05). (TIFF 17785 kb)
###end p 63
###begin p 64
We thank Jeffrey E. Segall for the GFP-MTLn3-ErbB1 cells, valuable discussion and critically reading of the manuscript. We are also grateful to Leo Price for critically reading the manuscript. This work was financially supported by grants from the Dutch Cancer Society (UL 2006-3538 and UL 2007-3860), the EU FP7 Health Program Metafight (Grant agreement no.201862), the Netherlands Organization for Scientific Research (902-21-229 and 911-02-022) and TI Pharma (T3-107).
###end p 64
###begin p 65
###xml 0 11 0 11 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Open Access</bold>
Open Access This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
###end p 65
###begin title 66
References
###end title 66
###begin article-title 67
Estimates of the cancer incidence and mortality in Europe in 2006
###end article-title 67
###begin article-title 68
Dissecting the metastatic cascade
###end article-title 68
###begin article-title 69
Cancer metastasis: building a framework
###end article-title 69
###begin article-title 70
Focal adhesion kinase: a potential target in cancer therapy
###end article-title 70
###begin article-title 71
Modelling breast cancer: one size does not fit all
###end article-title 71
###begin article-title 72
###xml 34 38 <span type="species:ncbi:10090">mice</span>
Defective lymphoid development in mice lacking expression of the common cytokine receptor gamma chain
###end article-title 72
###begin article-title 73
Modeling metastasis in vivo
###end article-title 73
###begin article-title 74
###xml 11 16 <span type="species:ncbi:10090">mouse</span>
###xml 41 46 <span type="species:ncbi:10090">mouse</span>
The mighty mouse: genetically engineered mouse models in cancer drug development
###end article-title 74
###begin article-title 75
###xml 40 46 <span type="species:ncbi:10090">murine</span>
From genetic abnormality to metastases: murine models of breast cancer and their use in the development of anticancer therapies
###end article-title 75
###begin article-title 76
###xml 107 110 <span type="species:ncbi:10116">rat</span>
Development and biologic properties of malignant cell sublines and clones of a spontaneously metastasizing rat mammary adenocarcinoma
###end article-title 76
###begin article-title 77
###xml 24 27 <span type="species:ncbi:10116">rat</span>
Characterisation of two rat mammary tumour models for breast cancer research by gene expression profiling
###end article-title 77
###begin article-title 78
ERBB receptors and cancer: the complexity of targeted inhibitors
###end article-title 78
###begin article-title 79
Breast cancer markers
###end article-title 79
###begin article-title 80
Intravital imaging of cell movement in tumours
###end article-title 80
###begin article-title 81
The great escape: when cancer cells hijack the genes for chemotaxis and motility
###end article-title 81
###begin article-title 82
Epidermal growth factor receptor overexpression results in increased tumor cell motility in vivo coordinately with enhanced intravasation and metastasis
###end article-title 82
###begin article-title 83
Natural killer cells, viruses and cancer
###end article-title 83
###begin article-title 84
###xml 48 53 <span type="species:ncbi:9606">human</span>
###xml 121 125 <span type="species:ncbi:10090">mice</span>
Comparative study on the metastatic behavior of human tumors in nude, beige/nude/xid and severe combined immunodeficient mice
###end article-title 84
###begin article-title 85
###xml 69 78 <span type="species:ncbi:10090">nude mice</span>
Incidence and pathological features of spontaneous tumors in athymic nude mice
###end article-title 85
###begin article-title 86
###xml 8 13 <span type="species:ncbi:9606">human</span>
###xml 59 64 <span type="species:ncbi:10090">mouse</span>
Primary human breast carcinomas transplantable in the nude mouse
###end article-title 86
###begin article-title 87
###xml 10 15 <span type="species:ncbi:9606">human</span>
###xml 37 46 <span type="species:ncbi:10090">nude mice</span>
Growth of human breast carcinomas in nude mice and subsequent establishment in tissue culture
###end article-title 87
###begin article-title 88
###xml 10 15 <span type="species:ncbi:9606">human</span>
###xml 48 52 <span type="species:ncbi:10090">mice</span>
###xml 57 66 <span type="species:ncbi:10090">nude mice</span>
Growth of human tumors in immune-deficient scid mice and nude mice
###end article-title 88
###begin article-title 89
###xml 52 57 <span type="species:ncbi:9606">human</span>
###xml 76 80 <span type="species:ncbi:10090">mice</span>
A comparative study on the xenotransplantability of human solid tumors into mice with different genetic immune deficiencies
###end article-title 89
###begin article-title 90
###xml 10 15 <span type="species:ncbi:9606">human</span>
###xml 36 45 <span type="species:ncbi:10090">nude mice</span>
###xml 50 54 <span type="species:ncbi:10090">mice</span>
Growth of human tumor xenografts in nude mice and mice with severe combined immunodeficiency (SCID)
###end article-title 90
###begin article-title 91
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 102 106 <span type="species:ncbi:10090">mice</span>
Human breast cancer cell line xenografts as models of breast cancer. The immunobiologies of recipient mice and the characteristics of several tumorigenic cell lines
###end article-title 91
###begin article-title 92
Requirement for focal adhesion kinase in the early phase of mammary adenocarcinoma lung metastasis formation
###end article-title 92
###begin article-title 93
An improved method to study NK-independent mechanisms of MTLn3 breast cancer lung metastasis
###end article-title 93
###begin article-title 94
Phenotypic drift of metastatic and cell-surface properties of mammary adenocarcinoma cell clones during growth in vitro
###end article-title 94
###begin article-title 95
Differential regulation of doxorubicin-induced mitochondrial dysfunction and apoptosis by Bcl-2 in mammary adenocarcinoma (MTLn3) cells
###end article-title 95
###begin article-title 96
Imaging of cancer invasion and metastasis using green fluorescent protein
###end article-title 96
###begin article-title 97
A critical step in metastasis: in vivo analysis of intravasation at the primary tumor
###end article-title 97
###begin article-title 98
###xml 16 20 <span type="species:ncbi:10090">mice</span>
RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement
###end article-title 98
###begin article-title 99
A paracrine loop between tumor cells and macrophages is required for tumor cell migration in mammary tumors
###end article-title 99
###begin article-title 100
Direct visualization of macrophage-assisted tumor cell intravasation in mammary tumors
###end article-title 100
###begin article-title 101
###xml 26 31 <span type="species:ncbi:10090">mouse</span>
The beige mutation in the mouse selectively impairs natural killer cell function
###end article-title 101
###begin article-title 102
###xml 26 31 <span type="species:ncbi:10090">mouse</span>
The beige mutation in the mouse I A stem cell predetermined impairment in natural killer cell function
###end article-title 102
###begin article-title 103
Imagable 4T1 model for the study of late stage breast cancer
###end article-title 103
###begin article-title 104
Natural killer cells and cancer
###end article-title 104
###begin article-title 105
Acute alcohol intoxication suppresses natural killer cell activity and promotes tumor metastasis
###end article-title 105
###begin article-title 106
Evidence that stress and surgical interventions promote tumor development by suppressing natural killer cell activity
###end article-title 106
###begin article-title 107
Rho family GTPases regulate mammary epithelium cell growth and metastasis through distinguishable pathways
###end article-title 107
###begin article-title 108
Marginating pulmonary-NK activity and resistance to experimental tumor metastasis: suppression by surgery and the prophylactic use of a beta-adrenergic antagonist and a prostaglandin synthesis inhibitor
###end article-title 108
###begin article-title 109
###xml 73 77 <span type="species:ncbi:10090">mice</span>
Natural killer cells in breast cancer cell growth and metastasis in SCID mice
###end article-title 109
###begin article-title 110
###xml 25 30 <span type="species:ncbi:9606">human</span>
###xml 92 96 <span type="species:ncbi:10090">mice</span>
Efficient engraftment of human primary breast cancer transplants in nonconditioned NOD/Scid mice
###end article-title 110
###begin article-title 111
Macrophages: obligate partners for tumor cell migration, invasion, and metastasis
###end article-title 111
###begin article-title 112
###xml 74 78 <span type="species:ncbi:10090">mice</span>
Macrophages mediate inflammation-enhanced metastasis of ovarian tumors in mice
###end article-title 112
###begin article-title 113
###xml 40 46 <span type="species:ncbi:10090">murine</span>
###xml 71 76 <span type="species:ncbi:9606">human</span>
Early detection of bone metastases in a murine model using fluorescent human breast cancer cells: application to the use of the bisphosphonate zoledronic acid in the treatment of osteolytic lesions
###end article-title 113
###begin article-title 114
###xml 55 60 <span type="species:ncbi:10090">mouse</span>
Optical imaging of cancer metastasis to bone marrow: a mouse model of minimal residual disease
###end article-title 114
###begin article-title 115
Down-regulation of WAVE3, a metastasis promoter gene, inhibits invasion and metastasis of breast cancer cells
###end article-title 115
###begin article-title 116
A novel orthotopic model of breast cancer metastasis to bone
###end article-title 116
###begin article-title 117
###xml 66 70 <span type="species:ncbi:10090">mice</span>
The natural history and immunopathology of outbred athymic (nude) mice
###end article-title 117
###begin article-title 118
###xml 12 17 <span type="species:ncbi:10090">mouse</span>
###xml 19 25 <span type="species:ncbi:10090">murine</span>
###xml 52 57 <span type="species:ncbi:9606">human</span>
The SCID-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function
###end article-title 118
###begin article-title 119
###xml 41 45 <span type="species:ncbi:10090">mice</span>
Natural killer (NK) cells are present in mice with severe combined immunodeficiency (scid)
###end article-title 119
###begin article-title 120
Nature of the scid defect: a defective VDJ recombinase system
###end article-title 120
###begin article-title 121
###xml 34 38 <span type="species:ncbi:10090">mice</span>
Homozygous scid/scid; beige/beige mice have low levels of spontaneous or neonatal T cell-induced B cell generation
###end article-title 121
###begin article-title 122
###xml 55 60 <span type="species:ncbi:10090">mouse</span>
###xml 122 128 <span type="species:ncbi:10090">murine</span>
Dissecting NK cell development using a novel alymphoid mouse model: investigating the role of the c-abl proto-oncogene in murine NK cell differentiation
###end article-title 122
###begin article-title 123
Deficient cellular immunity-finding and fixing the defects
###end article-title 123
###begin title 124
Abbreviations
###end title 124
###begin p 125
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 38 42 <span type="species:ncbi:10090">mice</span>
Mice severe combined immunodeficiency mice
###end p 125
###begin p 126
Recombinase activating gene
###end p 126
###begin p 127
Common gamma chain
###end p 127
###begin p 128
Fluorescence activated cell sorter
###end p 128
###begin p 129
Epidermal growth factor receptor
###end p 129
###begin p 130
Plasmid green fluorescent protein
###end p 130
###begin p 131
Interleukin 2
###end p 131
###begin p 132
Major histocompatibility complex
###end p 132
###begin p 133
Cell natural killer cell
###end p 133
###begin p 134
Fluorescent imaging
###end p 134
###begin p 135
Allophycocyanin
###end p 135
###begin p 136
###xml 0 33 0 33 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Electronic supplementary material</bold>
Electronic supplementary material
###end p 136
###begin p 137
The online version of this article (doi:10.1007/s10585-009-9267-6) contains supplementary material, which is available to authorized users.
###end p 137

